<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Vitamin A and beta (β)‐carotene supplementation for cystic fibrosis - de Vries, JJV - 2018 | Cochrane Library</title> <meta content="Vitamin A and beta (β)‐carotene supplementation for cystic fibrosis - de Vries, JJV - 2018 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006751.pub5/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Vitamin A and beta (β)‐carotene supplementation for cystic fibrosis - de Vries, JJV - 2018 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006751.pub5/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD006751.pub5" name="dc.identifier" scheme="DOI"/> <meta content="Vitamin A and beta (β)‐carotene supplementation for cystic fibrosis" name="citation_title"/> <meta content="Jorrit JV de Vries" name="citation_author"/> <meta content="University of Groningen" name="citation_author_institution"/> <meta content="jjvdevries@gmail.com" name="citation_author_email"/> <meta content="Anne B Chang" name="citation_author"/> <meta content="Menzies School of Health Research, Charles Darwin University" name="citation_author_institution"/> <meta content="Catherine M Bonifant" name="citation_author"/> <meta content="Children's Health Queensland, Lady Cilento Children's Hospital" name="citation_author_institution"/> <meta content="Elizabeth Shevill" name="citation_author"/> <meta content="Royal Children's Hospital" name="citation_author_institution"/> <meta content="Julie M Marchant" name="citation_author"/> <meta content="Centre for Children's Health Research" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="8" name="citation_issue"/> <meta content="10.1002/14651858.CD006751.pub5" name="citation_doi"/> <meta content="2018" name="citation_date"/> <meta content="2018/08/09" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006751.pub5/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006751.pub5/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006751.pub5/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="beta Carotene [*administration &amp; dosage]; Cystic Fibrosis [*complications]; Provitamins [*administration &amp; dosage]; Randomized Controlled Trials as Topic; Vitamin A [*administration &amp; dosage, adverse effects]; Vitamin A Deficiency [*prevention &amp; control]; Vitamins [*administration &amp; dosage, adverse effects]" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006751.pub5&amp;doi=10.1002/14651858.CD006751.pub5&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006751.pub5&amp;doi=10.1002/14651858.CD006751.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006751.pub5&amp;doi=10.1002/14651858.CD006751.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006751.pub5&amp;doi=10.1002/14651858.CD006751.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006751.pub5&amp;doi=10.1002/14651858.CD006751.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006751.pub5&amp;doi=10.1002/14651858.CD006751.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006751.pub5&amp;doi=10.1002/14651858.CD006751.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006751.pub5&amp;doi=10.1002/14651858.CD006751.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006751.pub5&amp;doi=10.1002/14651858.CD006751.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006751.pub5&amp;doi=10.1002/14651858.CD006751.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006751.pub5&amp;doi=10.1002/14651858.CD006751.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006751.pub5&amp;doi=10.1002/14651858.CD006751.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006751.pub5&amp;doi=10.1002/14651858.CD006751.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006751.pub5&amp;doi=10.1002/14651858.CD006751.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006751.pub5&amp;doi=10.1002/14651858.CD006751.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006751.pub5&amp;doi=10.1002/14651858.CD006751.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006751.pub5&amp;doi=10.1002/14651858.CD006751.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006751.pub5&amp;doi=10.1002/14651858.CD006751.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006751.pub5&amp;doi=10.1002/14651858.CD006751.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006751.pub5&amp;doi=10.1002/14651858.CD006751.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006751.pub5&amp;doi=10.1002/14651858.CD006751.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006751.pub5&amp;doi=10.1002/14651858.CD006751.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006751.pub5&amp;doi=10.1002/14651858.CD006751.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773519000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773548000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000"}};Liferay.authToken="i9CklieH";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD006751\x2epub5\x26doi\x3d10\x2e1002\x2f14651858\x2eCD006751\x2epub5\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006751\x2epub5\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006751\x2epub5\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513680837000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","fa","es","zh_HANS","zh_HANT","ru","ms","ja"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD006751.pub5",title:"Vitamin A and beta (\\u03B2)\\u2010carotene supplementation for cystic fibrosis",firstPublishedDate:"Aug 9, 2018 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Cystic Fibrosis and Genetic Disorders Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734739000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=i9CklieH&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD006751.pub5&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD006751.pub5';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD006751.pub5/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD006751.pub5/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD006751.pub5%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD006751.pub5/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD006751.pub5/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD006751.pub5/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD006751.pub5/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD006751.PUB5" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;ja&quot;,&quot;title&quot;:&quot;一般語訳&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;简语概要&quot;},{&quot;language&quot;:&quot;zh_HANT&quot;,&quot;title&quot;:&quot;淺顯易懂的口語結論&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD006751.pub5/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD006751.PUB5" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD006751.pub5/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD006751.pub5/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>2927 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD006751.pub5" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006751.pub5/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006751.pub5/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006751.pub5/full#CD006751-abs-0002"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006751.pub5/full#CD006751-sec-0080"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006751.pub5/full#CD006751-sec-0008"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006751.pub5/full#CD006751-sec-0009"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006751.pub5/full#CD006751-sec-0014"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006751.pub5/full#CD006751-sec-0015"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006751.pub5/full#CD006751-sec-0038"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006751.pub5/full#CD006751-sec-0074"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD006751.pub5/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006751.pub5/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006751.pub5/appendices#CD006751-sec-0085"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006751.pub5/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006751.pub5/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD006751.pub5/media/CDSR/CD006751/table_n/CD006751StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD006751.pub5/media/CDSR/CD006751/table_n/CD006751StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006751.pub5/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006751.pub5/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006751.pub5/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD006751.pub5/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD006751.pub5/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD006751.pub5/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2018 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD006751.pub5/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Vitamin A and beta (β)‐carotene supplementation for cystic fibrosis</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD006751.pub5/information#CD006751-cr-0004"><i class="icon corresponding-author fa fa-envelope"></i>Jorrit JV de Vries</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD006751.pub5/information#CD006751-cr-0005">Anne B Chang</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD006751.pub5/information#CD006751-cr-0006">Catherine M Bonifant</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD006751.pub5/information#CD006751-cr-0007">Elizabeth Shevill</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD006751.pub5/information#CD006751-cr-0008">Julie M Marchant</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD006751.pub5/information/en#CD006751-sec-0090">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 09 August 2018 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD006751.pub5/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD006751.pub5">https://doi.org/10.1002/14651858.CD006751.pub5</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD006751-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD006751-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD006751-abs-0011">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD006751-abs-0009">فارسی</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD006751-abs-0003">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD006751-abs-0001" lang="en"> <section id="CD006751-sec-0001"> <h3 class="title" id="CD006751-sec-0001">Background</h3> <p>People with cystic fibrosis (CF) and pancreatic insufficiency are at risk of a deficiency in fat‐soluble vitamins, including vitamin A. Vitamin A deficiency predominantly causes eye and skin problems, while excessive levels of vitamin A can harm the respiratory and skeletal systems in children and interfere with the metabolism of other fat‐soluble vitamins. Most CF centres administer vitamin A as supplements to reduce the frequency of vitamin A deficiency in people with CF and to improve clinical outcomes such as growth, although the recommended dose varies between different guidelines. Thus, a systematic review on vitamin A and vitamin A‐like supplementation (carotenes or other retinoids) in people with CF would help guide clinical practice. This is an update of an earlier Cochrane Review. </p> </section> <section id="CD006751-sec-0002"> <h3 class="title" id="CD006751-sec-0002">Objectives</h3> <p>To determine if supplementation with vitamin A, carotenes or other retinoid supplements in children and adults with CF reduces the frequency of vitamin A deficiency disorders, improves general and respiratory health and affects the frequency of vitamin A toxicity. </p> </section> <section id="CD006751-sec-0003"> <h3 class="title" id="CD006751-sec-0003">Search methods</h3> <p>We searched the Cochrane Cystic Fibrosis and Genetic Disorders Group Cystic Fibrosis Trials Register compiled from electronic database searches and handsearching of journals and conference abstract books. Additionally we searched several ongoing trials registries, including ClinicalTrials.gov, the WHO International Clinical Trials Registry Platform and the International Standard Randomised Controlled Trial Number Registry. </p> <p>Most recent database searches: 01 June 2018.</p> </section> <section id="CD006751-sec-0004"> <h3 class="title" id="CD006751-sec-0004">Selection criteria</h3> <p>All randomised or quasi‐randomised controlled studies comparing all preparations of oral vitamin A, carotenes or retinoids (or in combination), used as a supplement compared to placebo at any dose, for at least three months, in people with CF (diagnosed by sweat tests or genetic testing) with and without pancreatic insufficiency. </p> </section> <section id="CD006751-sec-0005"> <h3 class="title" id="CD006751-sec-0005">Data collection and analysis</h3> <p>Two authors individually assessed study quality and extracted data on outcome measures. The authors assessed the quality of the evidence using the GRADE system. Investigators were contacted to retrieve missing quantitative data. </p> </section> <section id="CD006751-sec-0006"> <h3 class="title" id="CD006751-sec-0006">Main results</h3> <p>No studies of vitamin A or other retinoid supplementation were eligible for inclusion. However, one randomised study of beta (β)‐carotene supplementation involving 24 people with CF who were receiving pancreatic enzyme substitution was included. The study compared successive β‐carotene supplementation periods (high dose followed by low dose) compared to placebo. The results for the low‐dose supplementation period should be interpreted with caution, due to the lack of a wash‐out period after the high‐dose supplementation. </p> <p>The included study did not report on two of the review's primary outcomes (vitamin A deficiency disorders and mortality); results for our third primary outcome of growth and nutritional status (reported as z score for height) showed no difference between supplementation and placebo, mean difference (MD) ‐0.23 (95% confidence interval (CI) ‐0.89 to 0.43) (low‐quality evidence). With regards to secondary outcomes, supplementation with high‐dose β‐carotene for three months led to significantly fewer days of systemic antibiotics required to treat pulmonary exacerbations, compared to controls, MD ‐15 days (95% CI ‐27.60 to ‐2.40); however, this was not maintained in the second three‐month section of the study when the level of β‐carotene supplementation was reduced, MD ‐8 days (95% CI ‐18.80 to 2.80) (low‐quality evidence). There were no statistically significant effects between groups in lung function (low‐quality evidence) and no adverse events were observed (low‐quality evidence). Supplementation affected levels of β‐carotene in plasma, but not vitamin A levels. The study did not report on quality of life or toxicity. </p> </section> <section id="CD006751-sec-0007"> <h3 class="title" id="CD006751-sec-0007">Authors' conclusions</h3> <p>Since no randomised or quasi‐randomised controlled studies on retinoid supplementation were identified, no conclusion on the supplementation of vitamin A in people with CF can be drawn. Additionally, due to methodological limitations in the included study, also reflected in the low‐quality evidence judged following the specific evidence grading system (GRADE), no clear conclusions on β‐carotene supplementation can be drawn. Until further data are available, country‐ or region‐specific guidelines regarding these practices should be followed. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD006751-abs-0002" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD006751-abs-0002">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD006751-abs-0012">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD006751-abs-0010">فارسی</a> </li> <li class="section-language"> <a class="" href="full/ja#CD006751-abs-0008">日本語</a> </li> <li class="section-language"> <a class="" href="full/ms#CD006751-abs-0007">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/ru#CD006751-abs-0006">Русский</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD006751-abs-0004">简体中文</a> </li> <li class="section-language"> <a class="" href="full/zh_HANT#CD006751-abs-0005">繁體中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD006751-abs-0002" lang="en"> <h3>The use of regular vitamin A or vitamin A‐like preparations for children and adults with cystic fibrosis </h3> <p><b>Review question</b> </p> <p>We reviewed the evidence regarding the effect of regular vitamin A or vitamin A‐like (carotenes or other retinoids) supplements in children and adults with cystic fibrosis. </p> <p><b>Background</b> </p> <p>In people with cystic fibrosis only a small proportion of some vitamins, such as vitamin A, may be absorbed by the body and lead to problems caused by vitamin deficiency. A lack of vitamin A (vitamin A deficiency) can cause eye and skin problems and is associated with poorer general and respiratory health. Therefore, people with cystic fibrosis are usually supplemented with regular vitamin A preparations from a very young age. However, too much vitamin A can cause bone and liver problems. Excessive carotene levels are known to cause carotenaemia, a harmless, reversible yellowing of the skin, whilst a lack of carotene is not known to cause adverse manifestations in individuals with normal vitamin A levels. </p> <p><b>Search date</b> </p> <p>The evidence is current to: 01 June 2018.</p> <p><b>Study characteristics</b> </p> <p>No studies comparing vitamin A or other retinoid supplements to placebo (dummy drug containing no vitamin A) were included, but we did find one study comparing beta‐carotene supplementation (a precursor of vitamin A) to placebo. A total of 24 people with cystic fibrosis (aged 6.7 to 27.7 years) were put into groups at random and treated either with β‐carotene capsules (at a high dose for three months followed by a low dose for a further three months) or with placebo (for six months). </p> <p><b>Key results</b> </p> <p>No studies on vitamin A supplementation were included in this review.</p> <p>The single included study revealed that high‐dose beta‐carotene supplementation for three months led to fewer days on which people with CF required antibiotics compared to placebo, but this was not the case in the following three‐month section of the study when low‐dose beta‐carotene supplementation was compared to placebo. Other clinical outcome measures (growth, nutritional status and lung function) showed no statistical significant differences between treatment and placebo groups. No side effects were observed. The other outcomes in this review, such as vitamin A deficiency symptoms, mortality, toxicity and quality of life, were not reported. </p> <p><b>Quality of the evidence</b> </p> <p>We could only include one study in this review and that study had several limitations. This is reflected in the assessment of low‐quality evidence, judged using the specific evidence grading system (GRADE). So, we feel that the strength of evidence is low. Not all outcome measures were reported after each supplementation dose and results should be viewed with some caution as some beta‐carotene from the high‐dose period was probably still present in the blood during the low‐dose supplementation period. </p> <p><b>Conclusions</b> </p> <p>Since no studies on vitamin A supplementation were included in the review, no conclusions can be drawn regarding the routine use of vitamin A supplements. Due to limitations of the included study of beta‐carotene supplementation, no definitive conclusions regarding its use can be drawn either. Until further evidence is available, local guidelines should be followed regarding supplementation. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD006751-sec-0080" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD006751-sec-0080"></div> <h3 class="title" id="CD006751-sec-0081">Implications for practice</h3> <section id="CD006751-sec-0081"> <p>As there were no randomised or quasi‐randomised controlled studies on vitamin A or retinoid supplementation included, we cannot draw any conclusions on the benefits (or otherwise) of regular administration of these supplements in people with cystic fibrosis (CF). In addition, although beta (β)‐carotene supplementation was beneficial in one clinical outcome measure (need for antibiotics), interpretation should be cautious due to methodological limitations, restraining the ability to draw clear conclusions. Until further data are available, country‐ or region‐specific guidelines (e.g. UK CF Trust Nutrition Guidelines (<a href="./references#CD006751-bbs2-0014" title="UK Cystic Fibrosis Trust Nutrition Working Group. Nutritional management of cystic fibrosis. UK Cystic Fibrosis Trust Consensus Document on Nutritional Management2016.">CF Trust 2016</a>)) on the use and monitoring of vitamin A, carotenes or other retinoids in people with CF should be followed. </p> </section> <h3 class="title" id="CD006751-sec-0082">Implications for research</h3> <section id="CD006751-sec-0082"> <p>There is an obvious need for a well‐designed, adequately‐powered, multicentre, parallel, randomised controlled study to assess if vitamin A or vitamin A‐like (carotenes or other retinoids) supplementation, in children and adults with CF is beneficial or otherwise. The study should examine if the administered supplementations positively or negatively influence the frequency of symptoms of vitamin A deficiency or general and respiratory outcomes. The possible negative effects should be examined in light of recent data showing possible harm when micronutrients are used in people who are not micronutrient‐deficient. Safety monitoring during such a study would be important as the current practice is to use supplementation of vitamin A in people with CF. Vitamin A levels should be measured before and during the studies when clinically stable and related to serum albumin and retinol binding protein. Studies involving both children and adults are required and results should be related to nutritional status and pancreatic status. Data relating to appropriate dose, frequency of supplementation and type of formulation of vitamin A, retinoids or carotenes are also needed. However, it is unlikely that well‐designed, randomised studies will be conducted in near future, given the costs involved and current CF research priorities. Furthermore, current widespread practice is to prescribe multivitamin preparations to people with CF, raising logistical problems for future studies to administer solely preparations of vitamin A. Thus, to examine the effect of vitamin A, retinoid or carotene supplementation in people with CF, evidence may come inevitably from studies with different designs (pro‐ and retrospective cohort studies) leading to less robust quality evidence. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD006751-sec-0008" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD006751-sec-0008"></div> <div class="table" id="CD006751-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Summary of findings</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>β‐carotene supplementation</b> <b>compared to placebo in children and adults with CF</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population</b>: children and adults with CF </p> <p><b>Settings</b>: outpatient </p> <p><b>Intervention</b>: β‐carotene supplementation (month 1 to 3: high‐dose (1 mg/kg/day (max 50 mg/day); month 4 to 6: low‐dose (10 mg/day)) </p> <p><b>Comparison</b>: placebo </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign=""> <p><b>Relative effect</b> </p> <p><b>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>No of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Quality of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Assumed risk</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Corresponding risk</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Placebo</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>β‐carotene supplementation</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Vitamin A deficiency disorders</b> </p> <p>Follow‐up: NA</p> </td> <td align="" class="table-tint table-highlight" colspan="3" rowspan="1" valign="top"> <p>Outcome not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>We planned to assess visual impairment, any other ocular dysfunction and skin manifestations, but the included study did not report any of these. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Growth and nutritional status:</b> <br/><b>z‐score for height</b> </p> <p>Follow‐up: At 6 months (low‐dose)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean (SD) z score for height at 6 months was ‐0.81 (0.63) in the placebo group.</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean z score for height was 0.23 lower</p> <p>(0.89 lower to 0.43 higher) in the supplementation group.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>24</p> <p>(1 study)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/><b>Low<sup>1,2</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>We planned to assess weight (kg and z score), height (cm and z score) and BMI.</p> <p>No separate analysable weight data were reported, height was only reported as a z score and the authors stated no differences between groups for BMI. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mortality</b> </p> <p>Follow‐up: NA</p> </td> <td align="" class="table-tint table-highlight" colspan="3" rowspan="1" valign="top"> <p>Outcome not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Respiratory outcomes: FEV<sub>1</sub> (% predicted):</b> </p> <p>Follow‐up: At 3 months (high‐dose)</p> <p>Follow‐up: At 6 months (low‐dose)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>At 3 months mean (SD) FEV<sub>1</sub> (% predicted) was 82.2% (15.1) in the placebo group. </p> <p>At 6 months mean (SD) FEV<sub>1</sub> (% predicted) was 80.3% (19.1) in the placebo group. </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>At 3 months mean FEV<sub>1</sub> (% predicted) was 10.6% lower (31.1% lower to 9.9% higher) in the supplementation group. </p> <p>At 6 months mean FEV<sub>1</sub> (% predicted) was 10.3% lower (31.6% lower to 11.0% higher) in the supplementation group. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>24</p> <p>(1 study)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/><b>Low<sup>1,2</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Respiratory outcomes: Antibiotic days per patient in past 3 months</b> </p> <p>Follow‐up: At 3 months (high‐dose)</p> <p>Follow‐up: At 6 months (low‐dose)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>At 3 months the mean (SD) number of antibiotic days was 24.8 (19.1) days in the placebo group. </p> <p>At 6 months the mean (SD) number of antibiotic days was 18.5 (15.8) days in the placebo group. </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>At 3 months the mean number of antibiotic days was 15.0 days lower (27.6 lower to 2.4 lower) in the supplementation group. </p> <p>At 6 months the mean number of antibiotic days was 8.0 days lower (18.8 days lower to 2.8 days higher) in the supplementation group. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>24</p> <p>(1 study)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/><b>Low<sup>1,2</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse events</b> </p> <p>Follow‐up: At 6 months<br/>(low‐dose) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>No adverse events reported.</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>No adverse events reported.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>24<br/>(1 study) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/><b>Low</b><sup>1,3</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Authors only mentioned that no adverse events were observed, without specification.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> is the event rate in the control group across studies. The <b>corresponding risk</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CF</b> : cystic fibrosis; <b>CI</b> : confidence interval; <b>FEV<sub>1</sub> </b> : forced expiratory volume in 1 second; <b>NA</b> : Not applicable; <b>SD</b>: standard deviation. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/><b>High quality</b> : further research is very unlikely to change our confidence in the estimate of effect.<br/><b>Moderate quality</b> : further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/><b>Low quality</b> : further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/><b>Very low quality</b>: we are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p>1. Downgraded once due risk of bias: unclear information relating to methodology such method of generation of random sequence, allocation concealment and blinding. Also due to the lack of an adequate wash‐out period post high‐dose supplementation, results post low‐dose supplementation might not be fully representative, increasing the risk of bias due to study design. </p> <p>2. Downgraded once due to imprecision: The CI crosses no difference and due to the wide CI minor differences are not ruled out. </p> <p>3. Downgraded once as no data are provided, only narrative.</p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD006751-sec-0009" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD006751-sec-0009"></div> <section id="CD006751-sec-0010"> <h3 class="title" id="CD006751-sec-0010">Description of the condition</h3> <p>Cystic fibrosis (CF) is a genetic disorder that affects multiple organs. Pancreatic insufficiency affects up to 90% of people with CF, whereby fat malabsorption occurs and pancreatic enzyme replacement is required to prevent steatorrhoea and malnutrition (<a href="./references#CD006751-bbs2-0017" title="DodgeJA , TurckD . Cystic fibrosis: nutritional consequences and management. Best Practice &amp; Research. Clinical Gastroenterology2006;20(3):531-46. [DOI: 10.1016/j.bpg.2005.11.006] [PMID: 16782527]">Dodge 2006</a>). Fat soluble vitamins (A, D, E and K) are co‐absorbed with fat and thus deficiency of these vitamins may occur (<a href="./references#CD006751-bbs2-0017" title="DodgeJA , TurckD . Cystic fibrosis: nutritional consequences and management. Best Practice &amp; Research. Clinical Gastroenterology2006;20(3):531-46. [DOI: 10.1016/j.bpg.2005.11.006] [PMID: 16782527]">Dodge 2006</a>). Most CF centres now routinely administer these vitamins as supplements from the neonatal period, but the recommendations differ among the major CF centres (<a href="./references#CD006751-bbs2-0032" title="LiL , SomersetS . Dietary intake and nutritional status of micronutrients in adults with cystic fibrosis in relation to current recommendations. Clinical Nutrition2016;35(4):775-82. [DOI: 10.1016/j.clnu.2015.06.004] [PMID: 26159903]">Li 2016</a>). In the past, a few centres have administered them only later in life or when deficiencies are detected clinically or on routine monitoring. While deficiencies may occur from the disease process of CF and insufficient supplementation, vitamin toxicity may also occur from excess supplementation. Both deficiency and excess of these vitamins may lead to specific medical problems (<a href="./references#CD006751-bbs2-0017" title="DodgeJA , TurckD . Cystic fibrosis: nutritional consequences and management. Best Practice &amp; Research. Clinical Gastroenterology2006;20(3):531-46. [DOI: 10.1016/j.bpg.2005.11.006] [PMID: 16782527]">Dodge 2006</a>; <a href="./references#CD006751-bbs2-0025" title="Hammond BR Jr, RenziLM . Carotenoids. Advances in Nutrition2013;4(4):474-6. [DOI: 10.3945/an.113.004028] [PMID: 23858095]">Hammond 2013</a>; <a href="./references#CD006751-bbs2-0043" title="SethuramanU . Vitamins. Pediatric Review2006;27(2):44-55. [PMID: 16452274]">Sethuraman 2006</a>). Current guidelines judged the available evidence for routine vitamin A supplementation as insufficient to guide practice, their recommendations are, however, based on non‐randomised trials and expert opinion (<a href="./references#CD006751-bbs2-0041" title="Clinical Guidelines: Care of Children with Cystic Fibrosis: Royal Brompton Hospital (7th edition) 2017. www.rbht.nhs.uk/childrencf (accessed 07 February 2017).">Royal Brompton Hospital 2017</a>; <a href="./references#CD006751-bbs2-0042" title="SaxbyN , PainterC , KenchA , KingS , CrowderT , van derHaakN , et al. Nutrition Guidelines for Cystic Fibrosis in Australia and New Zealand. Thoracic Society of Australia and New Zealand https://www.thoracic.org.au/documents/item/1045 (accessed 16 January 2018).">Saxby 2017</a>). </p> <p>Vitamin A is an essential nutrient for epithelial cell maintenance and repair in the respiratory, urinary and intestinal tract, immune response, and bone growth (<a href="./references#CD006751-bbs2-0042" title="SaxbyN , PainterC , KenchA , KingS , CrowderT , van derHaakN , et al. Nutrition Guidelines for Cystic Fibrosis in Australia and New Zealand. Thoracic Society of Australia and New Zealand https://www.thoracic.org.au/documents/item/1045 (accessed 16 January 2018).">Saxby 2017</a>). Dietary vitamin A (retinol or retinol esters) is found in liver, beef, eggs, fish, the fat of dairy products and vitamin A fortified margarine. Both alpha (α)‐ and beta (β)‐carotene can act as precursors for the synthesis of vitamin A. The dietary carotenoid (β‐carotene) is found in red, orange, yellow and leafy green vegetables (e.g. carrots, sweet potato and silverbeet) and red and orange fruit (e.g. mangos and oranges). Like vitamin A, β‐carotene is an antioxidant, which plays a role in coping with the oxidative stress that results from inflammatory and infectious processes in CF (<a href="./references#CD006751-bbs2-0011" title="CantinAM , WhiteTB , CrossCE , FormanHJ , SokolRJ , BorowitzD . Antioxidants in cystic fibrosis. Conclusions from the CF Antioxidant Workshop, Bethesda, Maryland, November 11-12, 2003. Free Radical Biology and Medicine2007;42(1):15-31. [DOI: 10.1016/j.freeradbiomed.2006.09.022] [PMID: 17157190]">Cantin 2007</a>). </p> <p>Vitamin A may be obtained from dietary sources by multiple pathways, either in its direct form as retinol‐esters, or indirectly as β‐carotene, which is partly converted to retinol (<a href="./references#CD006751-bbs2-0026" title="HarrisonE . Mechanisms involved in the intestinal absorption of dietary vitamin A and provitamin A carotenoids. Biochimica et biophysica acta2012;1821(1):70-7. [DOI: 10.1016/j.bbalip.2011.06.002] [PMID: 21718801]">Harrison 2012</a>). In the direct pathway, the long‐chain fatty acids of retinol are hydrolysed by pancreatic enzymes and enzymes released by intestinal cells (<a href="./references#CD006751-bbs2-0026" title="HarrisonE . Mechanisms involved in the intestinal absorption of dietary vitamin A and provitamin A carotenoids. Biochimica et biophysica acta2012;1821(1):70-7. [DOI: 10.1016/j.bbalip.2011.06.002] [PMID: 21718801]">Harrison 2012</a>). Since up to 90% of people with CF suffer from pancreatic insufficiency (<a href="./references#CD006751-bbs2-0017" title="DodgeJA , TurckD . Cystic fibrosis: nutritional consequences and management. Best Practice &amp; Research. Clinical Gastroenterology2006;20(3):531-46. [DOI: 10.1016/j.bpg.2005.11.006] [PMID: 16782527]">Dodge 2006</a>), fat uptake, and thereby also the uptake of fat‐soluble vitamins including vitamin A, is restrained. Absorption of β‐carotene and its conversion to retinol are not withheld by a decreased pancreas function, β‐carotene uptake is partly converted to retinol, a precursor of other forms of vitamin A, which can be reduced to retinol (<a href="./references#CD006751-bbs2-0038" title="PaikJ , DuringA , HarrisonEH , MendelsohnCL , LaiK , BlanerWS . Expression and characterization of a murine enzyme able to cleave beta-carotene. The formation of retinoids. The Journal of biological chemistry2001;276(34):32160-8. [DOI: 10.1074/jbc.M010086200] [PMID: 11418584]">Paik 2001</a>). Although β‐carotene absorption is theoretically not impaired in people with CF, it is unknown whether β‐carotene supplementation improves vitamin A serum concentrations. </p> <p>Vitamin A deficiency can be defined as a serum retinol (SROL) concentration less than 0.70 µmol/L (less than 20 µg/dl) (<a href="./references#CD006751-bbs2-0048" title="West KP Jr. Vitamin A deficiency disorders in children and women. Food and Nutrition Bulletin2003;24(4 Suppl):S78-90. [PMID: 17016949]">West 2003</a>). However, SROL levels may be influenced by albumin and retinol binding protein (RBP) as well as acute illnesses with infection and inflammation (<a href="./references#CD006751-bbs2-0035" title="NapoliJL . Retinoic acid biosynthesis and metabolism. The FASEB journal : official publication of the Federation of American Societies for Experimental Biology1996;10(9):993-1001. [PMID: 8801182]">Napoli 1996</a>; <a href="./references#CD006751-bbs2-0046" title="StephensenCB , AlvarezJO , KohatsuJ , HardmeierR , Kennedy JI Jr, Gammon RB Jr. Vitamin A is excreted in the urine during acute infection. American Journal of Clinical Nutrition1994;60(3):388-92. [PMID: 8074070]">Stephensen 1994</a>). Levels of SROL should be measured while individuals are clinically stable (<a href="./references#CD006751-bbs2-0008" title="BorowitzD , BakerRD , StallingsV . Consensus report on nutrition for pediatric patients with cystic fibrosis. Journal of Pediatric Gastroenterology and Nutrition2002;35(3):246-59. [PMID: 12352509]">Borowitz 2002</a>; <a href="./references#CD006751-bbs2-0042" title="SaxbyN , PainterC , KenchA , KingS , CrowderT , van derHaakN , et al. Nutrition Guidelines for Cystic Fibrosis in Australia and New Zealand. Thoracic Society of Australia and New Zealand https://www.thoracic.org.au/documents/item/1045 (accessed 16 January 2018).">Saxby 2017</a>). Carotene deficiency has no defined serum concentrations (<a href="./references#CD006751-bbs2-0013" title="Centers for Disease Control and Prevention. Second national report on biochemical indicators of diet and nutrition in the U.S. population 2012; 2012 April. www.cdc.gov/nutritionreport/report.html (accessed prior to 08 November 2017). [https://www.cdc.gov/nutritionreport/report.html]">CDC 2012</a>), although some studies define β‐carotene reference values based on the 95% confidence interval (CI) of β‐carotene serum concentrations in healthy individuals (<a href="./references#CD006751-bbs2-0037" title="OlmedillaB , GranadoF , SouthonS , WrightAJA , BlancoI , Gil-MartinezE , et al. Serum concentrations of carotenoids and vitamins A, E, and C in control subjects from five European countries. British Journal of Nutrition2001;85(2):227-38. [DOI: 10.1079/BJN2000248] [PMID: 11242491]">Olmedilla 2001</a>; <a href="./references#CD006751-bbs2-0045" title="SochaP , SkorupaE , PawlowskaJ , WierzbickaA , DhawanA , JankowskaI , et al. Beta-carotene deficiency in cholestatic liver disease of childhood is caused by beta-carotene malabsorption. Journal of Pediatric Gastroenterology and Nutrition2010;51(1):106-9. [DOI: 10.1097/MPG.0b013e3181d1afff] [PMID: 20479682]">Socha 2010</a>). </p> <p>The major consequence of vitamin A deficiency is ocular dysfunction with abnormal dark adaptation (night blindness), conjunctival and corneal xerosis (thickening) which can lead to blindness (<a href="./references#CD006751-bbs2-0042" title="SaxbyN , PainterC , KenchA , KingS , CrowderT , van derHaakN , et al. Nutrition Guidelines for Cystic Fibrosis in Australia and New Zealand. Thoracic Society of Australia and New Zealand https://www.thoracic.org.au/documents/item/1045 (accessed 16 January 2018).">Saxby 2017</a>; <a href="./references#CD006751-bbs2-0048" title="West KP Jr. Vitamin A deficiency disorders in children and women. Food and Nutrition Bulletin2003;24(4 Suppl):S78-90. [PMID: 17016949]">West 2003</a>). Another consequence of vitamin A deficiency is the skin condition phrynoderma (a form of follicular hyperkeratosis associated with some micronutrient deficiencies). Vitamin A deficiency has also been linked to impaired mechanisms of host resistance to infection, poor growth and increased mortality in a study of mothers and children (<a href="./references#CD006751-bbs2-0048" title="West KP Jr. Vitamin A deficiency disorders in children and women. Food and Nutrition Bulletin2003;24(4 Suppl):S78-90. [PMID: 17016949]">West 2003</a>). On the other hand, hypervitaminosis A (excess levels of vitamin A) is associated with hepatotoxicity and bone problems (<a href="./references#CD006751-bbs2-0039" title="PennistonKL , TanumihardjoSA . The acute and chronic toxic effects of vitamin A. American Journal of Clinical Nutrition2006;83(2):191-201. [PMID: 16469975]">Penniston 2006</a>). Also, cross‐sectional studies have reported that up to 25% of children with CF do not require vitamin A supplementation as sufficient amounts were already available though their diet (<a href="./references#CD006751-bbs2-0009" title="BreiC , SimonA , KrawinkelMB , NaehrlichL . Individualized vitamin A supplementation for patients with cystic fibrosis. Clinical Nutrition (Edinburgh, Scotland)2013;32(5):805-10. [DOI: 10.1016/j.clnu.2013.01.009] [PMID: 23395254]">Brei 2013</a>; <a href="./references#CD006751-bbs2-0023" title="Graham-MaarRC , SchallJI , StettlerN , ZemelBS , StallingsVA . Elevated vitamin A intake and serum retinol in preadolescent children with cystic fibrosis. American Journal of Clinical Nutrition2006;84(1):174-82. [PMID: 16825693]">Graham‐Maar 2006</a>). </p> <p>Carotenes, including β‐carotene, are known to be effective in preventing radical‐ or oxidative stress initiated damage (<a href="./references#CD006751-bbs2-0030" title="KrinskyNI , JohnsonEJ . Carotenoid actions and their relation to health and disease. Molecular Aspects of Medicine2005;26(6):459-516. [PMID: 16309738]">Krinsky 2005</a>). However, as long as vitamin A levels are normal, adverse clinical manifestations of β‐carotene deficiency are unknown (<a href="./references#CD006751-bbs2-0011" title="CantinAM , WhiteTB , CrossCE , FormanHJ , SokolRJ , BorowitzD . Antioxidants in cystic fibrosis. Conclusions from the CF Antioxidant Workshop, Bethesda, Maryland, November 11-12, 2003. Free Radical Biology and Medicine2007;42(1):15-31. [DOI: 10.1016/j.freeradbiomed.2006.09.022] [PMID: 17157190]">Cantin 2007</a>). Excessive intake of β‐carotene is known to cause carotenaemia, a harmless, reversible yellowing of the skin (<a href="./references#CD006751-bbs2-0031" title="LascariAD . Carotenemia. A review. Clinical Pediatrics1981;20(1):25-9. [PMID: 7449242]">Lascari 1981</a>). In general, most authors consider excessive intake of β‐carotene as nontoxic (<a href="./references#CD006751-bbs2-0011" title="CantinAM , WhiteTB , CrossCE , FormanHJ , SokolRJ , BorowitzD . Antioxidants in cystic fibrosis. Conclusions from the CF Antioxidant Workshop, Bethesda, Maryland, November 11-12, 2003. Free Radical Biology and Medicine2007;42(1):15-31. [DOI: 10.1016/j.freeradbiomed.2006.09.022] [PMID: 17157190]">Cantin 2007</a>; <a href="./references#CD006751-bbs2-0022" title="GalliF , BattistoniA , GambariR , PompellaA , BragonziA , PilolliF , et al. Oxidative stress and antioxidant therapy in cystic fibrosis. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease2012;1822(5):690-713. [DOI: 10.1016/j.bbadis.2011.12.012] [PMID: 22226887]">Galli 2012</a>; <a href="./references#CD006751-bbs2-0025" title="Hammond BR Jr, RenziLM . Carotenoids. Advances in Nutrition2013;4(4):474-6. [DOI: 10.3945/an.113.004028] [PMID: 23858095]">Hammond 2013</a>), although a meta‐analysis conducted by Bjelkovic and colleagues revealed that a daily intake of β‐carotene supplementation in a dose higher than the recommended daily allowances (β‐carotene equivalent to a dose of vitamin A of 800 µg = 9.6 mg β‐carotene) increased mortality amongst adults in the general population (<a href="./references#CD006751-bbs2-0007" title="BjelakovicG , NikolovaD , GluudC . Meta-regression analyses, meta-analyses, and trial sequential analyses of the effects of supplementation with beta-carotene, vitamin A, and vitamin E singly or in different combinations on all-cause mortality: do we have evidence for lack of harm?PloS one2013;8(9):e74558. [DOI: 10.1371/journal.pone.0074558] [PMID: 24040282]">Bjelakovic 2013</a>). Furthermore, β‐carotene supplementation in smokers and asbestos workers is associated with an increased risk of lung and gastric cancer (<a href="./references#CD006751-bbs2-0018" title="Druesne-PecolloN , Latino-MartelP , NoratT , BarrandonE , BertraisS , GalanP , et al. Beta-carotene supplementation and cancer risk: a systematic review and meta-analysis of randomized controlled trials. International Journal of Cancer2010;127(1):172-84. [DOI: 10.1002/ijc.25008] [PMID: 19876916]">Druesne 2010</a>). </p> </section> <section id="CD006751-sec-0011"> <h3 class="title" id="CD006751-sec-0011">Description of the intervention</h3> <p>Vitamin A is available as a sole supplement as well as in combination form with other vitamins as multivitamins (either as a liquid or a tablet). The availability of different formulations differ in different health services (<a href="./references#CD006751-bbs2-0023" title="Graham-MaarRC , SchallJI , StettlerN , ZemelBS , StallingsVA . Elevated vitamin A intake and serum retinol in preadolescent children with cystic fibrosis. American Journal of Clinical Nutrition2006;84(1):174-82. [PMID: 16825693]">Graham‐Maar 2006</a>). Vitamin A is usually administered as a daily dose, but the recommended doses vary in different guidelines. For example, the USA guidelines recommend daily supplementation of 10,000 IU from the age of eight years (<a href="./references#CD006751-bbs2-0008" title="BorowitzD , BakerRD , StallingsV . Consensus report on nutrition for pediatric patients with cystic fibrosis. Journal of Pediatric Gastroenterology and Nutrition2002;35(3):246-59. [PMID: 12352509]">Borowitz 2002</a>); whereas the Australian guidelines recommend a daily supplementation dose of 2500 IU to 5000 IU for older children, adolescents and adults (<a href="./references#CD006751-bbs2-0042" title="SaxbyN , PainterC , KenchA , KingS , CrowderT , van derHaakN , et al. Nutrition Guidelines for Cystic Fibrosis in Australia and New Zealand. Thoracic Society of Australia and New Zealand https://www.thoracic.org.au/documents/item/1045 (accessed 16 January 2018).">Saxby 2017</a>). Supplements of β‐carotene are available solely or in combination with other carotenoids or vitamins, or both; although β‐carotene supplementation is currently not recommended in CF (<a href="./references#CD006751-bbs2-0042" title="SaxbyN , PainterC , KenchA , KingS , CrowderT , van derHaakN , et al. Nutrition Guidelines for Cystic Fibrosis in Australia and New Zealand. Thoracic Society of Australia and New Zealand https://www.thoracic.org.au/documents/item/1045 (accessed 16 January 2018).">Saxby 2017</a>). </p> </section> <section id="CD006751-sec-0012"> <h3 class="title" id="CD006751-sec-0012">How the intervention might work</h3> <p>Normalisation of vitamin A levels may avoid the afore‐mentioned problems. However supplementation of these vitamins to excessive levels may cause harm to the skeletal system (osteoporosis and fractures) and liver abnormality in children with and without CF (<a href="./references#CD006751-bbs2-0023" title="Graham-MaarRC , SchallJI , StettlerN , ZemelBS , StallingsVA . Elevated vitamin A intake and serum retinol in preadolescent children with cystic fibrosis. American Journal of Clinical Nutrition2006;84(1):174-82. [PMID: 16825693]">Graham‐Maar 2006</a>; <a href="./references#CD006751-bbs2-0039" title="PennistonKL , TanumihardjoSA . The acute and chronic toxic effects of vitamin A. American Journal of Clinical Nutrition2006;83(2):191-201. [PMID: 16469975]">Penniston 2006</a>; <a href="./references#CD006751-bbs2-0043" title="SethuramanU . Vitamins. Pediatric Review2006;27(2):44-55. [PMID: 16452274]">Sethuraman 2006</a>). </p> </section> <section id="CD006751-sec-0013"> <h3 class="title" id="CD006751-sec-0013">Why it is important to do this review</h3> <p>Fat‐soluble vitamin supplementation varies between CF centres with differing guidelines and no uniform approach, both within regions and internationally. While vitamin A deficiency may be a problem, excess supplementation causing chronic hypervitaminosis A may also occur. Furthermore, it is not known whether there is a beneficial or harmful effect of carotene supplementation in people with CF. Thus a systematic review on the efficacy of vitamins A, D, E, K and antioxidant supplementation in children and adults with CF in preventing effects of the deficiency of these micronutrients would help guide clinical practice. Supplementation of vitamins D, E and K and other antioxidants has been addressed in other Cochrane Reviews (<a href="./references#CD006751-bbs2-0016" title="CiofuO , LykkesfeldtJ . Antioxidant supplementation for lung disease in cystic fibrosis. Cochrane Database of Systematic Reviews2014, Issue 8. [DOI: 10.1002/14651858.CD007020.pub3] [PMID: 25102015]">Ciofu 2014</a>; <a href="./references#CD006751-bbs2-0021" title="FergusonJH , ChangAB . Vitamin D supplementation for cystic fibrosis. Cochrane Database of Systematic Reviews2014, Issue 5. [DOI: 10.1002/14651858.CD007298.pub3] [PMID: 24823922]">Ferguson 2014</a>; <a href="./references#CD006751-bbs2-0029" title="JagannathVA , ThakerV , ChangAB , PriceAI . Vitamin K supplementation for cystic fibrosis. Cochrane Database of Systematic Reviews2017, Issue 8. [DOI: 10.1002/14651858.CD008482.pub5] [PMID: 28829533]">Jagannath 2017</a>; <a href="./references#CD006751-bbs2-0036" title="OkebukolaPO , KansraS , BarrettJ . Vitamin E supplementation in people with cystic fibrosis. Cochrane Database of Systematic Reviews2017, Issue 3. [DOI: 10.1002/14651858.CD009422.pub3] [PMID: 28262916]">Okebukola 2017</a>). This review will evaluate vitamin A, carotene and other retinoid supplementation in children and adults with CF. This version of the review is an update of previous versions (<a href="./references#CD006751-bbs2-0050" title="BonifantCM , ShevillE , ChangAB . Vitamin A supplementation for cystic fibrosis. Cochrane Database of Systematic Reviews2012, Issue 8. [DOI: 10.1002/14651858.CD006751.pub3] [PMID: 22895955]">Bonifant 2012</a>; <a href="./references#CD006751-bbs2-0051" title="BonifantCM , ShevillE , ChangAB . Vitamin A supplementation for cystic fibrosis. Cochrane Database of Systematic Reviews2014, Issue 5. [DOI: 10.1002/14651858.CD006751.pub4] [PMID: 24823814]">Bonifant 2014</a>; <a href="./references#CD006751-bbs2-0052" title="O'NeilCM , ShevillE , ChangAB . Vitamin A supplementation for cystic fibrosis. Cochrane Database of Systematic Reviews2008, Issue 1. [DOI: 10.1002/14651858.CD006751.pub2] [PMID: 18254115]">O'Neil 2008</a>). </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD006751-sec-0014" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD006751-sec-0014"></div> <p>To determine if, in children and adults with CF, vitamin A, carotene and other retinoid supplementation: </p> <p> <ol id="CD006751-list-0001"> <li> <p>reduces the frequency of vitamin A deficiency disorders;</p> </li> <li> <p>improves general and respiratory health;</p> </li> <li> <p>affects the frequency of vitamin A toxicity.</p> </li> </ol> </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD006751-sec-0015" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD006751-sec-0015"></div> <section id="CD006751-sec-0016"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD006751-sec-0017"> <h4 class="title">Types of studies</h4> <p>Randomised (RCTs) and quasi‐RCTs. We will assess cross‐over trials on a case‐by‐case basis and inclusion will depend on the data available given the potential for carry‐over effects of treatment. </p> </section> <section id="CD006751-sec-0018"> <h4 class="title">Types of participants</h4> <p>Children or adults with CF (defined by sweat tests or genetic testing) with and without pancreatic insufficiency. </p> </section> <section id="CD006751-sec-0019"> <h4 class="title">Types of interventions</h4> <p>All preparations of oral vitamin A, carotene or other retinoids used as a supplement compared to either no supplementation or placebo at any dose for at least three months. </p> </section> <section id="CD006751-sec-0020"> <h4 class="title">Types of outcome measures</h4> <section id="CD006751-sec-0021"> <h5 class="title">Primary outcomes</h5> <p> <ol id="CD006751-list-0002"> <li> <p>Vitamin A deficiency disorders</p> <ol id="CD006751-list-0003"> <li> <p>visual impairment</p> </li> <li> <p>any other ocular dysfunction</p> </li> <li> <p>skin manifestations</p> </li> </ol> </li> <li> <p>Growth and nutritional status</p> <ol id="CD006751-list-0004"> <li> <p>weight (kg and z score)</p> </li> <li> <p>height (cm and z score)</p> </li> <li> <p>body mass index (BMI)</p> </li> </ol> </li> <li> <p>Mortality</p> </li> </ol> </p> </section> <section id="CD006751-sec-0022"> <h5 class="title">Secondary outcomes</h5> <p> <ol id="CD006751-list-0005"> <li> <p>Respiratory outcomes</p> <ol id="CD006751-list-0006"> <li> <p>bronchiectasis severity control (Likert scale, visual analogue scale or radiological score (<a href="./references#CD006751-bbs2-0034" title="MarchantJM , MaselJP , DickinsonFL , MastersIB , ChangAB . Application of chest high-resolution computer tomography in young children with cystic fibrosis. Pediatric Pulmonology2001;31(1):24-9. [PMID: 11180671]">Marchant 2001</a>)) </p> </li> <li> <p>lung function indices</p> <ol id="CD006751-list-0007"> <li> <p>forced expiratory volume in one second (FEV<sub>1</sub>) </p> </li> <li> <p>forced vital capacity (FVC)</p> </li> </ol> </li> <li> <p>proportions of participants who had respiratory exacerbations or hospitalisations or both </p> </li> <li> <p>total number of hospitalised days or days off work or school</p> </li> </ol> </li> <li> <p>Quality of life</p> </li> <li> <p>Adverse events (including vomiting, loss of appetite, osteoporosis, fractures and any other adverse event noted) </p> </li> <li> <p>Possible toxicity events</p> </li> <li> <p>Measured levels of vitamin A, carotenes or other retinoids</p> </li> </ol> </p> <p>We planned to evaluate outcomes based on:</p> <p> <ol id="CD006751-list-0008"> <li> <p>short term (12 months or less); and</p> </li> <li> <p>medium to long term (longer than one year).</p> </li> </ol> </p> </section> </section> </section> <section id="CD006751-sec-0023"> <h3 class="title">Search methods for identification of studies</h3> <p>We searched for all relevant published and unpublished trials without restrictions on language, year or publication status. </p> <section id="CD006751-sec-0024"> <h4 class="title">Electronic searches</h4> <p>Previous versions of this review did not include carotene in the search terms (<a href="./references#CD006751-bbs2-0050" title="BonifantCM , ShevillE , ChangAB . Vitamin A supplementation for cystic fibrosis. Cochrane Database of Systematic Reviews2012, Issue 8. [DOI: 10.1002/14651858.CD006751.pub3] [PMID: 22895955]">Bonifant 2012</a>; <a href="./references#CD006751-bbs2-0050" title="BonifantCM , ShevillE , ChangAB . Vitamin A supplementation for cystic fibrosis. Cochrane Database of Systematic Reviews2012, Issue 8. [DOI: 10.1002/14651858.CD006751.pub3] [PMID: 22895955]">Bonifant 2012</a>; <a href="./references#CD006751-bbs2-0052" title="O'NeilCM , ShevillE , ChangAB . Vitamin A supplementation for cystic fibrosis. Cochrane Database of Systematic Reviews2008, Issue 1. [DOI: 10.1002/14651858.CD006751.pub2] [PMID: 18254115]">O'Neil 2008</a>). In this updated review, we identified relevant studies from the Group's Cystic Fibrosis Trials Register using the terms: Vitamin A OR *carotene OR retin*. </p> <p>The Cystic Fibrosis Trials Register is compiled from electronic searches of the Cochrane Central Register of Controlled Trials (CENTRAL) (updated each new issue of the Cochrane Library), weekly searches of MEDLINE, a search of Embase to 1995 and the prospective handsearching of two journals ‐ <i>Pediatric Pulmonology</i> and the <i>Journal of Cystic Fibrosis</i>. Unpublished work is identified by searching through the abstract books of three major cystic fibrosis conferences: the International Cystic Fibrosis Conference; the European Cystic Fibrosis Conference and the North American Cystic Fibrosis Conference. For full details of all searching activities for the register, please see the relevant sections of the Cystic Fibrosis and Genetic Disorders Group <a href="http://cfgd.cochrane.org/our-specialised-trials-registers" target="_blank">website</a>. </p> <p>Date of the most recent search of the Group’s Cystic Fibrosis Trials Register: 01 June 2018. </p> <p>We also searched the following trials registries:</p> <p> <ul id="CD006751-list-0009"> <li> <p>US National Institutes of Health Ongoing Trials Register Clinicaltrials.gov (<a href="http://www.clinicaltrials.gov" target="_blank">www.clinicaltrials.gov</a>; searched 09 June 2018); </p> </li> <li> <p>World Health Organization International Clinical Trials Registry Platform (WHO ICTRP) (<a href="http://apps.who.int/trialsearch" target="_blank">apps.who.int/trialsearch</a>; 09 June 2018); </p> </li> <li> <p>International Standard Randomised Controlled Trial Number (ISRCTN) Registry (<a href="http://www.isrctn.com" target="_blank">www.isrctn.com</a>; searched 09 June 2018). </p> </li> </ul> </p> <p>For details of our search strategies, please see <a href="./appendices#CD006751-sec-0086">Appendix 1</a>. </p> </section> <section id="CD006751-sec-0025"> <h4 class="title">Searching other resources</h4> <p>We checked the bibliographies of included studies and any relevant systematic reviews identified for further references to relevant trials. </p> </section> </section> <section id="CD006751-sec-0026"> <h3 class="title" id="CD006751-sec-0026">Data collection and analysis</h3> <p>The authors applied the process described below for data collection and analysis:</p> <section id="CD006751-sec-0027"> <h4 class="title">Selection of studies</h4> <p>From the title and abstract, two authors (JdV, JM) independently reviewed results of the literature searches to identify studies potentially relevant for further assessment. From these studies, the same two authors independently examined the papers in further detail in order to select studies for inclusion using the criteria stated above. The authors resolved disagreement by third party adjudication by another review author (AC). </p> </section> <section id="CD006751-sec-0028"> <h4 class="title">Data extraction and management</h4> <p>The authors (JdV, JM) reviewed studies that satisfied the inclusion criteria and independently extracted data on the outcomes described as follows: study setting; year of study; source of funding; participant recruitment details (including number of eligible participants); inclusion and exclusion criteria; randomisation and allocation concealment method; numbers of participants randomised; blinding (masking) of participants, care providers and outcome assessors; dose and type of intervention; duration of therapy; co‐interventions; numbers of participants not followed up; reasons for withdrawals from study protocol (clinical, side effects, refusal and other); side effects of therapy; and whether intention‐to‐treat analyses were possible. </p> <p>The authors planned to evaluate outcomes based on short term (12 months or less) and medium to long term (longer than one year), but due to data availability actually presented data at three months and six months. </p> <p>If, in future updates of this review, we extract data from studies on various supplements, outcome measures from different types of supplementation (vitamin A, carotenes and other retinoids) we will analyse these separately. </p> </section> <section id="CD006751-sec-0029"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two review authors (JdV, JM) independently assessed the risk of bias for each study using the criteria outlined in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD006751-bbs2-0028" title="HigginsJPT , GreenS , editor(s). Cochrane Handbook for Systematic Reviews of Interventions 5.1 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.">Higgins 2011</a>). We planned to resolve any disagreements by discussion or by involving another review author (AC). The review authors assessed the risk of bias according to the following domains: </p> <p> <ol id="CD006751-list-0010"> <li> <p>random sequence generation;</p> </li> <li> <p>allocation concealment;</p> </li> <li> <p>blinding of participants and personnel;</p> </li> <li> <p>blinding of outcome assessment;</p> </li> <li> <p>incomplete outcome data;</p> </li> <li> <p>selective outcome reporting; and</p> </li> <li> <p>other bias.</p> </li> </ol> </p> <p>The review authors graded each potential source of bias as high, low or unclear and provided a quote from the study report together with a justification for the judgment in the 'Risk of bias' (RoB) table. We then summarised the risk of bias judgements across different studies for each of the domains listed. We planned to blind separately for different key outcomes where necessary (e.g. for unblinded outcome assessment, risk of bias for all‐cause mortality may be very different than for a patient‐reported pain scale). Where information on risk of bias related to unpublished data or correspondence with a study author, we noted this in the 'Risk of bias' table. </p> <p>When considering treatment effects, the review authors took into account the risk of bias for the studies that contributed to that outcome. </p> </section> <section id="CD006751-sec-0030"> <h4 class="title">Measures of treatment effect</h4> <p>The review authors planned to analyse continuous outcomes (growth and nutritional status, respiratory outcomes, quality of life scores, and levels of vitamin A, carotenes or other retinoids) as the mean relative change from baseline for each group or mean post‐treatment or post‐intervention values and standard deviation (SD). We were only able to analyse the post intervention values in this version of the review. We then calculated a pooled estimate of treatment effect by the mean difference and 95% confidence intervals (CIs) using RevMan software (<a href="./references#CD006751-bbs2-0040" title="The Nordic Cochrane Centre, The Cochrane CollaborationReview Manager (RevMan). Version Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.">RevMan 2014</a>). </p> <p>No data were available for dichotomous outcomes (vitamin A deficiency disorders, mortality, adverse events and toxicity events). If such data becomes available in future updates of the review, the review authors will calculate the odds ratio (OR) and 95% CIs using a modified ITT analysis, i.e. if the original investigators did not use ITT analysis, they will consider dropouts to be failures. The authors will calculate numbers‐needed‐to‐treat (NNT) and their 95% CIs from the pooled OR and its 95% CIs for a specific baseline risk, which is the sum of all the events in the control groups (in all studies on that type of supplementation) divided by the total participant numbers in control groups in all studies on that type of supplementation using an online calculator (<a href="./references#CD006751-bbs2-0012" title="Visual Rx. Online NNT Calculator. Version 4. Cates C, 2016.Available at www.nntonline.net/.">Cates 2003</a>). </p> </section> <section id="CD006751-sec-0031"> <h4 class="title">Unit of analysis issues</h4> <p>We will assess cross‐over trials on a case‐by‐case basis and inclusion will depend on the data available given the potential for carry‐over effects of treatment. Cross‐over trials with dichotomous outcomes require more complicated analysis methods and for this the authors will consult with a statistician (<a href="./references#CD006751-bbs2-0020" title="ElbourneDR , AltmanDG , HigginsJPT , CurtinF , WorthingtonHV , VailA . Meta-analyses involving cross-over trials: methodological issues. International Journal of Epidemiology2002;31(1):140-9. [PMID: 11914310]">Elbourne 2002</a>). </p> </section> <section id="CD006751-sec-0032"> <h4 class="title">Dealing with missing data</h4> <p>We requested further information from the primary investigators (where required).</p> </section> <section id="CD006751-sec-0033"> <h4 class="title">Assessment of heterogeneity</h4> <p>Since only one study was included, no heterogeneity between studies could be assessed. When more studies are added to future versions of this review, we will describe any heterogeneity between study results and test this to see if it reaches statistical significance using a Chi² test. We will consider heterogeneity to be significant when the P value is less than 0.10 (<a href="./references#CD006751-bbs2-0028" title="HigginsJPT , GreenS , editor(s). Cochrane Handbook for Systematic Reviews of Interventions 5.1 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.">Higgins 2011</a>). The authors also plan to use the I² statistic to measure heterogeneity among the trials in each analysis, where heterogeneity is categorised such that a value of under 25% is considered low, around 50% is considered moderate and over 75% is considered a high degree of heterogeneity (<a href="./references#CD006751-bbs2-0027" title="HigginsJPT , ThompsonSG , DeeksJJ , AltmanDG . Measuring inconsistency in meta-analyses. BMJ2003;327(7414):557-60. [PMID: 12958120]">Higgins 2003</a>). </p> </section> <section id="CD006751-sec-0034"> <h4 class="title">Data synthesis</h4> <p>We analysed the data using a fixed‐effect model. However, in future updates of the review we will use the random‐effects model whenever there are concerns about statistical heterogeneity. </p> </section> <section id="CD006751-sec-0035"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We had planned to perform the following subgroup analyses to investigate any heterogeneity identified but were unable to do so as only one study was included: </p> <p> <ol id="CD006751-list-0011"> <li> <p>children (aged 18 years or less) and adults (over 18 years);</p> </li> <li> <p>formulations of the vitamin (single or multivitamin);</p> </li> <li> <p>vitamin A and vitamin A‐like (carotenes or other retinoids) supplementation;</p> </li> <li> <p>presence of pancreatic insufficiency.</p> </li> </ol> </p> </section> <section id="CD006751-sec-0036"> <h4 class="title">Sensitivity analysis</h4> <p>The review authors also planned to use sensitivity analyses to evaluate treatment effect by excluding trials with an high risk of bias (either as judged overall or for the specific domains of selection bias and blinding). </p> </section> <section id="CD006751-sec-0037"> <h4 class="title">Summary of findings table</h4> <p>In a post hoc change, we created a 'Summary of findings' table with the following outcomes included (<a href="./full#CD006751-tbl-0001">summary of findings Table 1</a>). </p> <p> <ol id="CD006751-list-0012"> <li> <p>Vitamin A deficiency disorders</p> </li> <li> <p>Growth and nutritional status</p> </li> <li> <p>Mortality</p> </li> <li> <p>FEV<sub>1</sub> (% predicted) </p> </li> <li> <p>Antibiotic days per participant in past three months</p> </li> <li> <p>Adverse events</p> </li> </ol> </p> <p>Based on the GRADE approach, we assessed the following factors influencing the quality level of the body of evidence of the included study. </p> <p> <ol id="CD006751-list-0013"> <li> <p>Limitations in the design and implementation</p> </li> <li> <p>Indirectness of evidence</p> </li> <li> <p>Unexplained heterogeneity or inconsistency of results</p> </li> <li> <p>Imprecision of results</p> </li> <li> <p>High probability of publication bias</p> </li> </ol> </p> <p>We justified all decisions to upgrade or downgrade the assessed quality of the currently only included study in footnotes. Since we were not able to include any studies comparing vitamin A supplementation with placebo in people with CF, we did not generate a summary of findings table for this comparison. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD006751-sec-0038" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD006751-sec-0038"></div> <section id="CD006751-sec-0039"> <h3 class="title">Description of studies</h3> <section id="CD006751-sec-0040"> <h4 class="title">Results of the search</h4> <p>The conducted search returned 14 references to six studies (<a href="./references#CD006751-bbs2-0002" title="CobanoğluN , OzçelikU , GöçmenA , KiperN , DoğruD . Antioxidant effect of beta-carotene in cystic fibrosis and bronchiectasis: clinical and laboratory parameters of a pilot study. Acta Paediatrica2002;91(7):793-8. [CFGD REGISTER: GN99] [PMID: 12200905]">Cobanoglu 2002</a>; <a href="./references#CD006751-bbs2-0003" title="GarićD , De SanctisJ , WojewodkaG , HouleD , CupriS , HajduchM , et al. Fenretinide differentially modulates the levels of long- and very long-chain ceramides by downregulating Cers5 enzyme: evidence from bench to bedside. Journal of Molecular Medicine (Berlin, Germany)2017;95(10):1053-64. GaricD , WojewodkaG , De SanctisJB , HajduchM , KoprivaF , PislariuR , et al. Fenretinide treatment increases long chain ceramide C24:0 and decreases short chain ceramide C16:0 levels in patients with cystic fibrosis (phase IB clinical trial). Pediatric pulmonology2015;50 Suppl 41:291. [ABSTRACT NO: 264] [CFGD REGISTER: GN253b] RadziochD , WojewodkaG , CupriS , ColinP , PislariuR , GarićD , et al. A novel oral formulation of fenretinide demonstrates safety and tolerability in a phase 1B dose-ascending trial involving adult cystic fibrosis patients. Pediatric Pulmonology2015;50 Suppl 41:290. [ABSTRACT NO: 261 ] [CFGD REGISTER: GN253c] WojewodkaG , MatoukE , De SanctisJB , PislariuR , ColinP , MatinC , et al. The cystic fibrosis associated fatty acid imbalance is corrected by a novel formulation of fenretinide in a phase 1B clinical trial. Pediatric Pulmonology2015;50 Suppl 41:289. [ABSTRACT NO: 260 ] [CFGD REGISTER: GN253a] ">Garić 2015</a>; <a href="./references#CD006751-bbs2-0004" title="HomnickDN , SpillersCR , CoxSR , CoxJH , YeltonLA , De LoofMJ , et al. Single- and multiple-dose response relationships of beta-carotene in cystic fibrosis. Journal of Pediatrics1995;127(3):491-4. [CFGD REGISTER: GN68] [PMID: 7658286]">Homnick 1995</a>; <a href="./references#CD006751-bbs2-0005" title="NCT01859390. Effects of an antioxidant-enriched multivitamin supplement on inflammation and oxidative stress in cystic fibrosis (AquADEKs-2) [A multi-center, randomized, controlled, double-blind study of the effects of an antioxidant-enriched multivitamin supplement on inflammation and oxidative stress in cystic fibrosis patients]. clinicaltrials.gov/ct2/show/NCT01859390 (first received 21 May 2013). ">NCT01859390</a>; <a href="./references#CD006751-bbs2-0001" title="EnglB , RustP , EichlerI , RennerS , ElmadfaI . Bioavailability of therapeutic Beta-Carotine (BC) in patients with cystic fibrosis (CF) and effects on anthropometrical parameters over 6 months [Bioverfugbarkeit einer therapeutischen Beta-Carotin (BC) Gabe bei Patienten mit zystischer Fibrose (CF) und Auswirkungen auf anthropometrische Parameter uber eine Versuchsdauer von 6 Monaten]. Monatsschrift fur Kinderheilkunde1997;145:S 134. [CENTRAL: 336058] [CFGD REGISTER: GN69g] RennerS , RathR , RustP , LehrS , FrischerT , ElmadfaI , et al. Effects of beta-carotene supplementation for six months on clinical and laboratory parameters in patients with cystic fibrosis. Thorax2001;56(1):48-52. [CENTRAL: 329478] [CFGD REGISTER: GN69f] [PMID: 11120904]RennerS , WojnarowskiC , KollerDY , RustP , ElmadfaI , EichlerI . Patients with cystic fibrosis (CF) benefit from β-carotene supplementation for 6 months. Pediatric Pulmonology1997;Suppl 14:314. [CENTRAL: 794966] [CFGD REGISTER: GN69a] RennerS , WojnarowskiC , KollerDY , RustP , ElmadfaI , EichlerI . Patients with cystic fibrosis (CF) benefit from beta-Carotene supplementation for 6 months. In: 22nd European Cystic Fibrosis Conference; 1998 June 13-19; Berlin, Germany. 1998:97. [CENTRAL: 794967] [CFGD REGISTER: GN69b] RustP , EichlerI , ElmadfaI . Influence of an oral beta-carotine-supplementation on the antioxidant status of patients with cystic fibrosis [Einfluss einer oralen beta-Karotin-Supplementierung auf den Antioxidantienstatus von Patienten mit zystischer Fibrose]. Atemwegs und Lungenkrankheiten1997;23:51. [CENTRAL: 255854] [CFGD REGISTER: GN69d] RustP , EichlerI , RennerS , ElmadfaI . Effects of long-term oral beta-carotene supplementation on lipid peroxidation in patients with cystic fibrosis. International Journal for Vitamin and Nutrition Research1998;68(2):83-7. [CENTRAL: 208549] [CFGD REGISTER: GN69c] [PMID: 9565821]RustP , EichlerI , RennerS , ElmadfaI . Long-term oral beta-carotene supplementation in patients with cystic fibrosis - effects on antioxidative status and pulmonary function. Annals of Nutrition &amp; Metabolism2000;44(1):30-7. [CENTRAL: 297191] [CFGD REGISTER: GN69e] [PMID: 10838464]">Rust 1998</a>; <a href="./references#CD006751-bbs2-0006" title="WoodLG , FitzgeraldDA , LeeAK , GargML . Improved antioxidant and fatty acid status of patients with cystic fibrosis after antioxidant supplementation is linked to improved lung function. American Journal of Clinical Nutrition2003;77(1):150-9. [CFGD REGISTER: GN98] [PMID: 12499335]">Wood 2003</a>). Full‐text papers were available for four studies. One study had only been published in the form of three abstracts; however, the authors kindly provided their unpublished manuscript including supplemental material (<a href="./references#CD006751-bbs2-0003" title="GarićD , De SanctisJ , WojewodkaG , HouleD , CupriS , HajduchM , et al. Fenretinide differentially modulates the levels of long- and very long-chain ceramides by downregulating Cers5 enzyme: evidence from bench to bedside. Journal of Molecular Medicine (Berlin, Germany)2017;95(10):1053-64. GaricD , WojewodkaG , De SanctisJB , HajduchM , KoprivaF , PislariuR , et al. Fenretinide treatment increases long chain ceramide C24:0 and decreases short chain ceramide C16:0 levels in patients with cystic fibrosis (phase IB clinical trial). Pediatric pulmonology2015;50 Suppl 41:291. [ABSTRACT NO: 264] [CFGD REGISTER: GN253b] RadziochD , WojewodkaG , CupriS , ColinP , PislariuR , GarićD , et al. A novel oral formulation of fenretinide demonstrates safety and tolerability in a phase 1B dose-ascending trial involving adult cystic fibrosis patients. Pediatric Pulmonology2015;50 Suppl 41:290. [ABSTRACT NO: 261 ] [CFGD REGISTER: GN253c] WojewodkaG , MatoukE , De SanctisJB , PislariuR , ColinP , MatinC , et al. The cystic fibrosis associated fatty acid imbalance is corrected by a novel formulation of fenretinide in a phase 1B clinical trial. Pediatric Pulmonology2015;50 Suppl 41:289. [ABSTRACT NO: 260 ] [CFGD REGISTER: GN253a] ">Garić 2015</a>). The flow of studies through the screening process of the review is presented in a flow diagram (<a href="#CD006751-fig-0001">Figure 1</a>). </p> <div class="figure" id="CD006751-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram" data-id="CD006751-fig-0001" src="/cdsr/doi/10.1002/14651858.CD006751.pub5/media/CDSR/CD006751/image_n/nCD006751-FIG-01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram</p> </div> </div> </div> </section> <section id="CD006751-sec-0041"> <h4 class="title">Included studies</h4> <p>Please see <a href="./references#CD006751-sec-0096" title="">Characteristics of included studies</a>. </p> <p>No studies of vitamin A or other retinoid supplementation that fulfilled the inclusion criteria were identified. One study on β‐carotene supplementation was included in this review (<a href="./references#CD006751-bbs2-0001" title="EnglB , RustP , EichlerI , RennerS , ElmadfaI . Bioavailability of therapeutic Beta-Carotine (BC) in patients with cystic fibrosis (CF) and effects on anthropometrical parameters over 6 months [Bioverfugbarkeit einer therapeutischen Beta-Carotin (BC) Gabe bei Patienten mit zystischer Fibrose (CF) und Auswirkungen auf anthropometrische Parameter uber eine Versuchsdauer von 6 Monaten]. Monatsschrift fur Kinderheilkunde1997;145:S 134. [CENTRAL: 336058] [CFGD REGISTER: GN69g] RennerS , RathR , RustP , LehrS , FrischerT , ElmadfaI , et al. Effects of beta-carotene supplementation for six months on clinical and laboratory parameters in patients with cystic fibrosis. Thorax2001;56(1):48-52. [CENTRAL: 329478] [CFGD REGISTER: GN69f] [PMID: 11120904]RennerS , WojnarowskiC , KollerDY , RustP , ElmadfaI , EichlerI . Patients with cystic fibrosis (CF) benefit from β-carotene supplementation for 6 months. Pediatric Pulmonology1997;Suppl 14:314. [CENTRAL: 794966] [CFGD REGISTER: GN69a] RennerS , WojnarowskiC , KollerDY , RustP , ElmadfaI , EichlerI . Patients with cystic fibrosis (CF) benefit from beta-Carotene supplementation for 6 months. In: 22nd European Cystic Fibrosis Conference; 1998 June 13-19; Berlin, Germany. 1998:97. [CENTRAL: 794967] [CFGD REGISTER: GN69b] RustP , EichlerI , ElmadfaI . Influence of an oral beta-carotine-supplementation on the antioxidant status of patients with cystic fibrosis [Einfluss einer oralen beta-Karotin-Supplementierung auf den Antioxidantienstatus von Patienten mit zystischer Fibrose]. Atemwegs und Lungenkrankheiten1997;23:51. [CENTRAL: 255854] [CFGD REGISTER: GN69d] RustP , EichlerI , RennerS , ElmadfaI . Effects of long-term oral beta-carotene supplementation on lipid peroxidation in patients with cystic fibrosis. International Journal for Vitamin and Nutrition Research1998;68(2):83-7. [CENTRAL: 208549] [CFGD REGISTER: GN69c] [PMID: 9565821]RustP , EichlerI , RennerS , ElmadfaI . Long-term oral beta-carotene supplementation in patients with cystic fibrosis - effects on antioxidative status and pulmonary function. Annals of Nutrition &amp; Metabolism2000;44(1):30-7. [CENTRAL: 297191] [CFGD REGISTER: GN69e] [PMID: 10838464]">Rust 1998</a>). </p> <section id="CD006751-sec-0042"> <h5 class="title">Trial design</h5> <p>The included study was conducted in a single centre in Vienna, Austria with a duration of six months. </p> </section> <section id="CD006751-sec-0043"> <h5 class="title">Participants</h5> <p>The study randomised 24 people (adults and children) with CF and included a cohort of 14 age‐matched healthy controls (data for this cohort not included in this review). The age of participants ranged from 6.7 years to 27.7 years; 25% of participants were male. </p> </section> <section id="CD006751-sec-0044"> <h5 class="title">Interventions</h5> <p>Rust and colleagues compared β‐carotene supplementation to placebo. The β‐carotene supplementation group received a high‐dose supplementation of 1 mg/kg/day β‐carotene (maximum 50 mg/day) for 12 weeks, followed by a weight‐independent low‐dose supplementation of 10 mg/day β‐carotene for a further 12 weeks. The placebo group received starch‐containing placebo capsules of identical appearance as the β‐carotene supplementation capsules for 24 weeks. All participants remained on any regular daily supplementation with multivitamins and pancreatic enzymes during the study period. </p> </section> <section id="CD006751-sec-0045"> <h5 class="title">Outcomes</h5> <p>Relevant data reported for this review were anthropometric outcome measures, respiratory outcome measures, adverse events and plasma concentrations of vitamin A and β‐carotene. </p> </section> </section> <section id="CD006751-sec-0046"> <h4 class="title">Excluded studies</h4> <p>Please see <a href="./references#CD006751-sec-0097" title="">Characteristics of excluded studies</a>. </p> <p>Five studies were excluded (<a href="./references#CD006751-bbs2-0002" title="CobanoğluN , OzçelikU , GöçmenA , KiperN , DoğruD . Antioxidant effect of beta-carotene in cystic fibrosis and bronchiectasis: clinical and laboratory parameters of a pilot study. Acta Paediatrica2002;91(7):793-8. [CFGD REGISTER: GN99] [PMID: 12200905]">Cobanoglu 2002</a>; <a href="./references#CD006751-bbs2-0003" title="GarićD , De SanctisJ , WojewodkaG , HouleD , CupriS , HajduchM , et al. Fenretinide differentially modulates the levels of long- and very long-chain ceramides by downregulating Cers5 enzyme: evidence from bench to bedside. Journal of Molecular Medicine (Berlin, Germany)2017;95(10):1053-64. GaricD , WojewodkaG , De SanctisJB , HajduchM , KoprivaF , PislariuR , et al. Fenretinide treatment increases long chain ceramide C24:0 and decreases short chain ceramide C16:0 levels in patients with cystic fibrosis (phase IB clinical trial). Pediatric pulmonology2015;50 Suppl 41:291. [ABSTRACT NO: 264] [CFGD REGISTER: GN253b] RadziochD , WojewodkaG , CupriS , ColinP , PislariuR , GarićD , et al. A novel oral formulation of fenretinide demonstrates safety and tolerability in a phase 1B dose-ascending trial involving adult cystic fibrosis patients. Pediatric Pulmonology2015;50 Suppl 41:290. [ABSTRACT NO: 261 ] [CFGD REGISTER: GN253c] WojewodkaG , MatoukE , De SanctisJB , PislariuR , ColinP , MatinC , et al. The cystic fibrosis associated fatty acid imbalance is corrected by a novel formulation of fenretinide in a phase 1B clinical trial. Pediatric Pulmonology2015;50 Suppl 41:289. [ABSTRACT NO: 260 ] [CFGD REGISTER: GN253a] ">Garić 2015</a>; <a href="./references#CD006751-bbs2-0004" title="HomnickDN , SpillersCR , CoxSR , CoxJH , YeltonLA , De LoofMJ , et al. Single- and multiple-dose response relationships of beta-carotene in cystic fibrosis. Journal of Pediatrics1995;127(3):491-4. [CFGD REGISTER: GN68] [PMID: 7658286]">Homnick 1995</a>; <a href="./references#CD006751-bbs2-0005" title="NCT01859390. Effects of an antioxidant-enriched multivitamin supplement on inflammation and oxidative stress in cystic fibrosis (AquADEKs-2) [A multi-center, randomized, controlled, double-blind study of the effects of an antioxidant-enriched multivitamin supplement on inflammation and oxidative stress in cystic fibrosis patients]. clinicaltrials.gov/ct2/show/NCT01859390 (first received 21 May 2013). ">NCT01859390</a>; <a href="./references#CD006751-bbs2-0006" title="WoodLG , FitzgeraldDA , LeeAK , GargML . Improved antioxidant and fatty acid status of patients with cystic fibrosis after antioxidant supplementation is linked to improved lung function. American Journal of Clinical Nutrition2003;77(1):150-9. [CFGD REGISTER: GN98] [PMID: 12499335]">Wood 2003</a>). One study was excluded since β‐carotene supplementation doses were individually adjusted based on β‐carotene plasma concentrations and no placebo supplementation was described (<a href="./references#CD006751-bbs2-0004" title="HomnickDN , SpillersCR , CoxSR , CoxJH , YeltonLA , De LoofMJ , et al. Single- and multiple-dose response relationships of beta-carotene in cystic fibrosis. Journal of Pediatrics1995;127(3):491-4. [CFGD REGISTER: GN68] [PMID: 7658286]">Homnick 1995</a>). A second study was excluded due to the lack of an appropriate control group as all children with CF received the same intervention (<a href="./references#CD006751-bbs2-0002" title="CobanoğluN , OzçelikU , GöçmenA , KiperN , DoğruD . Antioxidant effect of beta-carotene in cystic fibrosis and bronchiectasis: clinical and laboratory parameters of a pilot study. Acta Paediatrica2002;91(7):793-8. [CFGD REGISTER: GN99] [PMID: 12200905]">Cobanoglu 2002</a>). Furthermore, in two studies participants received combined supplements rather than just vitamin A (<a href="./references#CD006751-bbs2-0005" title="NCT01859390. Effects of an antioxidant-enriched multivitamin supplement on inflammation and oxidative stress in cystic fibrosis (AquADEKs-2) [A multi-center, randomized, controlled, double-blind study of the effects of an antioxidant-enriched multivitamin supplement on inflammation and oxidative stress in cystic fibrosis patients]. clinicaltrials.gov/ct2/show/NCT01859390 (first received 21 May 2013). ">NCT01859390</a>; <a href="./references#CD006751-bbs2-0006" title="WoodLG , FitzgeraldDA , LeeAK , GargML . Improved antioxidant and fatty acid status of patients with cystic fibrosis after antioxidant supplementation is linked to improved lung function. American Journal of Clinical Nutrition2003;77(1):150-9. [CFGD REGISTER: GN98] [PMID: 12499335]">Wood 2003</a>). The double‐blind placebo‐controlled study of fenretinide supplementation (an escalating daily dose schedule versus placebo) was excluded since the duration of supplementation at each dose level was only three weeks (outside our inclusion criteria) (<a href="./references#CD006751-bbs2-0003" title="GarićD , De SanctisJ , WojewodkaG , HouleD , CupriS , HajduchM , et al. Fenretinide differentially modulates the levels of long- and very long-chain ceramides by downregulating Cers5 enzyme: evidence from bench to bedside. Journal of Molecular Medicine (Berlin, Germany)2017;95(10):1053-64. GaricD , WojewodkaG , De SanctisJB , HajduchM , KoprivaF , PislariuR , et al. Fenretinide treatment increases long chain ceramide C24:0 and decreases short chain ceramide C16:0 levels in patients with cystic fibrosis (phase IB clinical trial). Pediatric pulmonology2015;50 Suppl 41:291. [ABSTRACT NO: 264] [CFGD REGISTER: GN253b] RadziochD , WojewodkaG , CupriS , ColinP , PislariuR , GarićD , et al. A novel oral formulation of fenretinide demonstrates safety and tolerability in a phase 1B dose-ascending trial involving adult cystic fibrosis patients. Pediatric Pulmonology2015;50 Suppl 41:290. [ABSTRACT NO: 261 ] [CFGD REGISTER: GN253c] WojewodkaG , MatoukE , De SanctisJB , PislariuR , ColinP , MatinC , et al. The cystic fibrosis associated fatty acid imbalance is corrected by a novel formulation of fenretinide in a phase 1B clinical trial. Pediatric Pulmonology2015;50 Suppl 41:289. [ABSTRACT NO: 260 ] [CFGD REGISTER: GN253a] ">Garić 2015</a>). </p> </section> </section> <section id="CD006751-sec-0047"> <h3 class="title">Risk of bias in included studies</h3> <p>The only included study was judged as having a unclear risk of bias overall (<a href="./references#CD006751-bbs2-0001" title="EnglB , RustP , EichlerI , RennerS , ElmadfaI . Bioavailability of therapeutic Beta-Carotine (BC) in patients with cystic fibrosis (CF) and effects on anthropometrical parameters over 6 months [Bioverfugbarkeit einer therapeutischen Beta-Carotin (BC) Gabe bei Patienten mit zystischer Fibrose (CF) und Auswirkungen auf anthropometrische Parameter uber eine Versuchsdauer von 6 Monaten]. Monatsschrift fur Kinderheilkunde1997;145:S 134. [CENTRAL: 336058] [CFGD REGISTER: GN69g] RennerS , RathR , RustP , LehrS , FrischerT , ElmadfaI , et al. Effects of beta-carotene supplementation for six months on clinical and laboratory parameters in patients with cystic fibrosis. Thorax2001;56(1):48-52. [CENTRAL: 329478] [CFGD REGISTER: GN69f] [PMID: 11120904]RennerS , WojnarowskiC , KollerDY , RustP , ElmadfaI , EichlerI . Patients with cystic fibrosis (CF) benefit from β-carotene supplementation for 6 months. Pediatric Pulmonology1997;Suppl 14:314. [CENTRAL: 794966] [CFGD REGISTER: GN69a] RennerS , WojnarowskiC , KollerDY , RustP , ElmadfaI , EichlerI . Patients with cystic fibrosis (CF) benefit from beta-Carotene supplementation for 6 months. In: 22nd European Cystic Fibrosis Conference; 1998 June 13-19; Berlin, Germany. 1998:97. [CENTRAL: 794967] [CFGD REGISTER: GN69b] RustP , EichlerI , ElmadfaI . Influence of an oral beta-carotine-supplementation on the antioxidant status of patients with cystic fibrosis [Einfluss einer oralen beta-Karotin-Supplementierung auf den Antioxidantienstatus von Patienten mit zystischer Fibrose]. Atemwegs und Lungenkrankheiten1997;23:51. [CENTRAL: 255854] [CFGD REGISTER: GN69d] RustP , EichlerI , RennerS , ElmadfaI . Effects of long-term oral beta-carotene supplementation on lipid peroxidation in patients with cystic fibrosis. International Journal for Vitamin and Nutrition Research1998;68(2):83-7. [CENTRAL: 208549] [CFGD REGISTER: GN69c] [PMID: 9565821]RustP , EichlerI , RennerS , ElmadfaI . Long-term oral beta-carotene supplementation in patients with cystic fibrosis - effects on antioxidative status and pulmonary function. Annals of Nutrition &amp; Metabolism2000;44(1):30-7. [CENTRAL: 297191] [CFGD REGISTER: GN69e] [PMID: 10838464]">Rust 1998</a>). Further details regarding different domains of bias are described under the subheadings below, in the risk of bias summary (<a href="#CD006751-fig-0002">Figure 2</a>) and in the risk of bias table below the '<a href="./references#CD006751-sec-0096" title="">Characteristics of included studies</a>' table. </p> <div class="figure" id="CD006751-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for the included study." data-id="CD006751-fig-0002" src="/cdsr/doi/10.1002/14651858.CD006751.pub5/media/CDSR/CD006751/image_n/nCD006751-FIG-02.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for the included study. </p> </div> </div> </div> <section id="CD006751-sec-0048"> <h4 class="title">Allocation</h4> <p>The risk of allocation bias is determined to be unclear, as neither the method of generation of the randomisation sequence, nor the method of allocation concealment were described in the included study (<a href="./references#CD006751-bbs2-0001" title="EnglB , RustP , EichlerI , RennerS , ElmadfaI . Bioavailability of therapeutic Beta-Carotine (BC) in patients with cystic fibrosis (CF) and effects on anthropometrical parameters over 6 months [Bioverfugbarkeit einer therapeutischen Beta-Carotin (BC) Gabe bei Patienten mit zystischer Fibrose (CF) und Auswirkungen auf anthropometrische Parameter uber eine Versuchsdauer von 6 Monaten]. Monatsschrift fur Kinderheilkunde1997;145:S 134. [CENTRAL: 336058] [CFGD REGISTER: GN69g] RennerS , RathR , RustP , LehrS , FrischerT , ElmadfaI , et al. Effects of beta-carotene supplementation for six months on clinical and laboratory parameters in patients with cystic fibrosis. Thorax2001;56(1):48-52. [CENTRAL: 329478] [CFGD REGISTER: GN69f] [PMID: 11120904]RennerS , WojnarowskiC , KollerDY , RustP , ElmadfaI , EichlerI . Patients with cystic fibrosis (CF) benefit from β-carotene supplementation for 6 months. Pediatric Pulmonology1997;Suppl 14:314. [CENTRAL: 794966] [CFGD REGISTER: GN69a] RennerS , WojnarowskiC , KollerDY , RustP , ElmadfaI , EichlerI . Patients with cystic fibrosis (CF) benefit from beta-Carotene supplementation for 6 months. In: 22nd European Cystic Fibrosis Conference; 1998 June 13-19; Berlin, Germany. 1998:97. [CENTRAL: 794967] [CFGD REGISTER: GN69b] RustP , EichlerI , ElmadfaI . Influence of an oral beta-carotine-supplementation on the antioxidant status of patients with cystic fibrosis [Einfluss einer oralen beta-Karotin-Supplementierung auf den Antioxidantienstatus von Patienten mit zystischer Fibrose]. Atemwegs und Lungenkrankheiten1997;23:51. [CENTRAL: 255854] [CFGD REGISTER: GN69d] RustP , EichlerI , RennerS , ElmadfaI . Effects of long-term oral beta-carotene supplementation on lipid peroxidation in patients with cystic fibrosis. International Journal for Vitamin and Nutrition Research1998;68(2):83-7. [CENTRAL: 208549] [CFGD REGISTER: GN69c] [PMID: 9565821]RustP , EichlerI , RennerS , ElmadfaI . Long-term oral beta-carotene supplementation in patients with cystic fibrosis - effects on antioxidative status and pulmonary function. Annals of Nutrition &amp; Metabolism2000;44(1):30-7. [CENTRAL: 297191] [CFGD REGISTER: GN69e] [PMID: 10838464]">Rust 1998</a>). </p> </section> <section id="CD006751-sec-0049"> <h4 class="title">Blinding</h4> <p>The risk associated with participant blinding was deemed to be low since the capsules for both supplements and placebo were identical. However, the risk of detection bias due to inadequate blinding was considered to be unclear, as it was not stated if the outcome assessor was blinded (<a href="./references#CD006751-bbs2-0001" title="EnglB , RustP , EichlerI , RennerS , ElmadfaI . Bioavailability of therapeutic Beta-Carotine (BC) in patients with cystic fibrosis (CF) and effects on anthropometrical parameters over 6 months [Bioverfugbarkeit einer therapeutischen Beta-Carotin (BC) Gabe bei Patienten mit zystischer Fibrose (CF) und Auswirkungen auf anthropometrische Parameter uber eine Versuchsdauer von 6 Monaten]. Monatsschrift fur Kinderheilkunde1997;145:S 134. [CENTRAL: 336058] [CFGD REGISTER: GN69g] RennerS , RathR , RustP , LehrS , FrischerT , ElmadfaI , et al. Effects of beta-carotene supplementation for six months on clinical and laboratory parameters in patients with cystic fibrosis. Thorax2001;56(1):48-52. [CENTRAL: 329478] [CFGD REGISTER: GN69f] [PMID: 11120904]RennerS , WojnarowskiC , KollerDY , RustP , ElmadfaI , EichlerI . Patients with cystic fibrosis (CF) benefit from β-carotene supplementation for 6 months. Pediatric Pulmonology1997;Suppl 14:314. [CENTRAL: 794966] [CFGD REGISTER: GN69a] RennerS , WojnarowskiC , KollerDY , RustP , ElmadfaI , EichlerI . Patients with cystic fibrosis (CF) benefit from beta-Carotene supplementation for 6 months. In: 22nd European Cystic Fibrosis Conference; 1998 June 13-19; Berlin, Germany. 1998:97. [CENTRAL: 794967] [CFGD REGISTER: GN69b] RustP , EichlerI , ElmadfaI . Influence of an oral beta-carotine-supplementation on the antioxidant status of patients with cystic fibrosis [Einfluss einer oralen beta-Karotin-Supplementierung auf den Antioxidantienstatus von Patienten mit zystischer Fibrose]. Atemwegs und Lungenkrankheiten1997;23:51. [CENTRAL: 255854] [CFGD REGISTER: GN69d] RustP , EichlerI , RennerS , ElmadfaI . Effects of long-term oral beta-carotene supplementation on lipid peroxidation in patients with cystic fibrosis. International Journal for Vitamin and Nutrition Research1998;68(2):83-7. [CENTRAL: 208549] [CFGD REGISTER: GN69c] [PMID: 9565821]RustP , EichlerI , RennerS , ElmadfaI . Long-term oral beta-carotene supplementation in patients with cystic fibrosis - effects on antioxidative status and pulmonary function. Annals of Nutrition &amp; Metabolism2000;44(1):30-7. [CENTRAL: 297191] [CFGD REGISTER: GN69e] [PMID: 10838464]">Rust 1998</a>). </p> </section> <section id="CD006751-sec-0050"> <h4 class="title">Incomplete outcome data</h4> <p>The included study was assessed as having a unclear risk of attrition bias, as the authors did not mention explicitly how they dealt with dropouts. However, 24 participants were analysed at baseline and post‐intervention; hence, although details on compliance were not provided, the study either used an intention‐to‐treat analysis or had no dropouts. (<a href="./references#CD006751-bbs2-0001" title="EnglB , RustP , EichlerI , RennerS , ElmadfaI . Bioavailability of therapeutic Beta-Carotine (BC) in patients with cystic fibrosis (CF) and effects on anthropometrical parameters over 6 months [Bioverfugbarkeit einer therapeutischen Beta-Carotin (BC) Gabe bei Patienten mit zystischer Fibrose (CF) und Auswirkungen auf anthropometrische Parameter uber eine Versuchsdauer von 6 Monaten]. Monatsschrift fur Kinderheilkunde1997;145:S 134. [CENTRAL: 336058] [CFGD REGISTER: GN69g] RennerS , RathR , RustP , LehrS , FrischerT , ElmadfaI , et al. Effects of beta-carotene supplementation for six months on clinical and laboratory parameters in patients with cystic fibrosis. Thorax2001;56(1):48-52. [CENTRAL: 329478] [CFGD REGISTER: GN69f] [PMID: 11120904]RennerS , WojnarowskiC , KollerDY , RustP , ElmadfaI , EichlerI . Patients with cystic fibrosis (CF) benefit from β-carotene supplementation for 6 months. Pediatric Pulmonology1997;Suppl 14:314. [CENTRAL: 794966] [CFGD REGISTER: GN69a] RennerS , WojnarowskiC , KollerDY , RustP , ElmadfaI , EichlerI . Patients with cystic fibrosis (CF) benefit from beta-Carotene supplementation for 6 months. In: 22nd European Cystic Fibrosis Conference; 1998 June 13-19; Berlin, Germany. 1998:97. [CENTRAL: 794967] [CFGD REGISTER: GN69b] RustP , EichlerI , ElmadfaI . Influence of an oral beta-carotine-supplementation on the antioxidant status of patients with cystic fibrosis [Einfluss einer oralen beta-Karotin-Supplementierung auf den Antioxidantienstatus von Patienten mit zystischer Fibrose]. Atemwegs und Lungenkrankheiten1997;23:51. [CENTRAL: 255854] [CFGD REGISTER: GN69d] RustP , EichlerI , RennerS , ElmadfaI . Effects of long-term oral beta-carotene supplementation on lipid peroxidation in patients with cystic fibrosis. International Journal for Vitamin and Nutrition Research1998;68(2):83-7. [CENTRAL: 208549] [CFGD REGISTER: GN69c] [PMID: 9565821]RustP , EichlerI , RennerS , ElmadfaI . Long-term oral beta-carotene supplementation in patients with cystic fibrosis - effects on antioxidative status and pulmonary function. Annals of Nutrition &amp; Metabolism2000;44(1):30-7. [CENTRAL: 297191] [CFGD REGISTER: GN69e] [PMID: 10838464]">Rust 1998</a>). </p> </section> <section id="CD006751-sec-0051"> <h4 class="title">Selective reporting</h4> <p>The risk of reporting bias was considered high in the included study, since not all outcome measures are reported at each endpoint (growth and nutritional status not reported post high‐dose supplementation) (<a href="./references#CD006751-bbs2-0001" title="EnglB , RustP , EichlerI , RennerS , ElmadfaI . Bioavailability of therapeutic Beta-Carotine (BC) in patients with cystic fibrosis (CF) and effects on anthropometrical parameters over 6 months [Bioverfugbarkeit einer therapeutischen Beta-Carotin (BC) Gabe bei Patienten mit zystischer Fibrose (CF) und Auswirkungen auf anthropometrische Parameter uber eine Versuchsdauer von 6 Monaten]. Monatsschrift fur Kinderheilkunde1997;145:S 134. [CENTRAL: 336058] [CFGD REGISTER: GN69g] RennerS , RathR , RustP , LehrS , FrischerT , ElmadfaI , et al. Effects of beta-carotene supplementation for six months on clinical and laboratory parameters in patients with cystic fibrosis. Thorax2001;56(1):48-52. [CENTRAL: 329478] [CFGD REGISTER: GN69f] [PMID: 11120904]RennerS , WojnarowskiC , KollerDY , RustP , ElmadfaI , EichlerI . Patients with cystic fibrosis (CF) benefit from β-carotene supplementation for 6 months. Pediatric Pulmonology1997;Suppl 14:314. [CENTRAL: 794966] [CFGD REGISTER: GN69a] RennerS , WojnarowskiC , KollerDY , RustP , ElmadfaI , EichlerI . Patients with cystic fibrosis (CF) benefit from beta-Carotene supplementation for 6 months. In: 22nd European Cystic Fibrosis Conference; 1998 June 13-19; Berlin, Germany. 1998:97. [CENTRAL: 794967] [CFGD REGISTER: GN69b] RustP , EichlerI , ElmadfaI . Influence of an oral beta-carotine-supplementation on the antioxidant status of patients with cystic fibrosis [Einfluss einer oralen beta-Karotin-Supplementierung auf den Antioxidantienstatus von Patienten mit zystischer Fibrose]. Atemwegs und Lungenkrankheiten1997;23:51. [CENTRAL: 255854] [CFGD REGISTER: GN69d] RustP , EichlerI , RennerS , ElmadfaI . Effects of long-term oral beta-carotene supplementation on lipid peroxidation in patients with cystic fibrosis. International Journal for Vitamin and Nutrition Research1998;68(2):83-7. [CENTRAL: 208549] [CFGD REGISTER: GN69c] [PMID: 9565821]RustP , EichlerI , RennerS , ElmadfaI . Long-term oral beta-carotene supplementation in patients with cystic fibrosis - effects on antioxidative status and pulmonary function. Annals of Nutrition &amp; Metabolism2000;44(1):30-7. [CENTRAL: 297191] [CFGD REGISTER: GN69e] [PMID: 10838464]">Rust 1998</a>). The authors specifically define pulmonary exacerbations and symptoms, but the prevalence of those exacerbations and symptoms is only reported indirectly, reflected in the amount of days on which systemic antibiotics were prescribed. Furthemore, modified Shwachmann‐Kulczycki scores were measured on a monthly basis but only baseline values were reported, although the authors did mention there were no statistical significant differences. Also, differences in the data for some outcome measures were identified in various manuscripts reporting the same study and same study population. </p> </section> <section id="CD006751-sec-0052"> <h4 class="title">Other potential sources of bias</h4> <p>The risk of other potential bias was judged as high. Besides a typical history of CF and sweat chloride levels over 60 mEq/L, no further inclusion or exclusion criteria were stated; it was also not stated whether participants were immunocompetent or if any were post‐transplant (potential for selection bias). The investigators measured the Shwachmann‐Kulczycki score without its included radiographical assessment as a clinical outcome measure; this is a modified version of the instrument that has not been validated. </p> <p>With regards to study design, the sample size in the included study is small and no power calculations were mentioned. Furthermore, the included study had a multi‐dose design with no washout period after the high‐dose supplementation and before the low‐dose supplementation and it is unclear whether this introduced any bias to the results. Since the half‐time of β‐carotene in plasma in healthy individuals is at least a week (<a href="./references#CD006751-bbs2-0010" title="BurriBJ , NeidlingerTR , CliffordAJ . Serum carotenoid depletion follows first-order kinetics in healthy adult women fed naturally low carotenoid diets. Journal of nutrition2001;131(8):2096-100. [PMID: 11481400]">Burri 2001</a>; <a href="./references#CD006751-bbs2-0019" title="DuekerSR , LinY , BuchholzBA , SchneiderPD , LaméMW , SegallHJ , et al. Long-term kinetic study of beta-carotene, using accelerator mass spectrometry in an adult volunteer. Journal of Lipid Research2000;41(11):1790-800. [PMID: 11060348]">Dueker 2000</a>; <a href="./references#CD006751-bbs2-0047" title="ThürmannPA , SteffenJ , ZwernemannC , AebischerCP , CohnW , WendtG , et al. Plasma concentration response to drinks containing beta-carotene as carrot juice or formulated as a water dispersible powder. European Journal of Nutrition2002;41(5):228-35. [DOI: 10.1007/s00394-002-0381-3] [PMID: 12395217]">Thürmann 2002</a>; <a href="./references#CD006751-bbs2-0049" title="WiseJA , KaatsGR , PreussHG , MorinRJ . beta-Carotene and alpha-tocopherol in healthy overweight adults; depletion kinetics are correlated with adiposity. International Journal of Food Sciences and Nutrition2009;60(Suppl 3):65-75. [DOI: 10.1080/09637480902852553] [PMID: 19391032]">Wise 2009</a>), the entire low‐dose supplementation period would be expected to be influenced by previous high‐dose supplementation and results should be interpreted with caution. </p> <p>Finally, no declaration of interest was stated, nor any details about funding, thus there is an unclear risk of bias due to these issues. </p> </section> </section> <section id="CD006751-sec-0053"> <h3 class="title" id="CD006751-sec-0053">Effects of interventions</h3> <p>See: <a href="./full#CD006751-tbl-0001"><b>Summary of findings 1</b> Summary of findings</a> </p> <section id="CD006751-sec-0054"> <h4 class="title">Vitamin A supplementation</h4> <p>The authors did not find any eligible studies on vitamin A supplementation that fulfilled the inclusion criteria. </p> </section> <section id="CD006751-sec-0055"> <h4 class="title">Carotene supplementation</h4> <p>One study (24 participants) on carotene supplementation was eligible for inclusion (<a href="./references#CD006751-bbs2-0001" title="EnglB , RustP , EichlerI , RennerS , ElmadfaI . Bioavailability of therapeutic Beta-Carotine (BC) in patients with cystic fibrosis (CF) and effects on anthropometrical parameters over 6 months [Bioverfugbarkeit einer therapeutischen Beta-Carotin (BC) Gabe bei Patienten mit zystischer Fibrose (CF) und Auswirkungen auf anthropometrische Parameter uber eine Versuchsdauer von 6 Monaten]. Monatsschrift fur Kinderheilkunde1997;145:S 134. [CENTRAL: 336058] [CFGD REGISTER: GN69g] RennerS , RathR , RustP , LehrS , FrischerT , ElmadfaI , et al. Effects of beta-carotene supplementation for six months on clinical and laboratory parameters in patients with cystic fibrosis. Thorax2001;56(1):48-52. [CENTRAL: 329478] [CFGD REGISTER: GN69f] [PMID: 11120904]RennerS , WojnarowskiC , KollerDY , RustP , ElmadfaI , EichlerI . Patients with cystic fibrosis (CF) benefit from β-carotene supplementation for 6 months. Pediatric Pulmonology1997;Suppl 14:314. [CENTRAL: 794966] [CFGD REGISTER: GN69a] RennerS , WojnarowskiC , KollerDY , RustP , ElmadfaI , EichlerI . Patients with cystic fibrosis (CF) benefit from beta-Carotene supplementation for 6 months. In: 22nd European Cystic Fibrosis Conference; 1998 June 13-19; Berlin, Germany. 1998:97. [CENTRAL: 794967] [CFGD REGISTER: GN69b] RustP , EichlerI , ElmadfaI . Influence of an oral beta-carotine-supplementation on the antioxidant status of patients with cystic fibrosis [Einfluss einer oralen beta-Karotin-Supplementierung auf den Antioxidantienstatus von Patienten mit zystischer Fibrose]. Atemwegs und Lungenkrankheiten1997;23:51. [CENTRAL: 255854] [CFGD REGISTER: GN69d] RustP , EichlerI , RennerS , ElmadfaI . Effects of long-term oral beta-carotene supplementation on lipid peroxidation in patients with cystic fibrosis. International Journal for Vitamin and Nutrition Research1998;68(2):83-7. [CENTRAL: 208549] [CFGD REGISTER: GN69c] [PMID: 9565821]RustP , EichlerI , RennerS , ElmadfaI . Long-term oral beta-carotene supplementation in patients with cystic fibrosis - effects on antioxidative status and pulmonary function. Annals of Nutrition &amp; Metabolism2000;44(1):30-7. [CENTRAL: 297191] [CFGD REGISTER: GN69e] [PMID: 10838464]">Rust 1998</a>). Data were limited and we contacted the investigators for additional information; unfortunately, although a reply was received, no further information could be provided. We judged the study to have an unclear risk of bias due to its design. Since no adequate washout period prior to low‐dose supplementation was implemented, outcome measures at the endpoint directly post low‐dose supplementation should be interpreted with caution (see <a href="./references#CD006751-sec-0084" title="">Data and analyses</a>; <a href="./full#CD006751-tbl-0001">summary of findings Table 1</a>). </p> <section id="CD006751-sec-0056"> <h5 class="title">Primary outcomes</h5> <section id="CD006751-sec-0057"> <h6 class="title">1. Vitamin A deficiency disorders</h6> <p>The only included study did not report on any vitamin A deficiency disorders (<a href="./references#CD006751-bbs2-0001" title="EnglB , RustP , EichlerI , RennerS , ElmadfaI . Bioavailability of therapeutic Beta-Carotine (BC) in patients with cystic fibrosis (CF) and effects on anthropometrical parameters over 6 months [Bioverfugbarkeit einer therapeutischen Beta-Carotin (BC) Gabe bei Patienten mit zystischer Fibrose (CF) und Auswirkungen auf anthropometrische Parameter uber eine Versuchsdauer von 6 Monaten]. Monatsschrift fur Kinderheilkunde1997;145:S 134. [CENTRAL: 336058] [CFGD REGISTER: GN69g] RennerS , RathR , RustP , LehrS , FrischerT , ElmadfaI , et al. Effects of beta-carotene supplementation for six months on clinical and laboratory parameters in patients with cystic fibrosis. Thorax2001;56(1):48-52. [CENTRAL: 329478] [CFGD REGISTER: GN69f] [PMID: 11120904]RennerS , WojnarowskiC , KollerDY , RustP , ElmadfaI , EichlerI . Patients with cystic fibrosis (CF) benefit from β-carotene supplementation for 6 months. Pediatric Pulmonology1997;Suppl 14:314. [CENTRAL: 794966] [CFGD REGISTER: GN69a] RennerS , WojnarowskiC , KollerDY , RustP , ElmadfaI , EichlerI . Patients with cystic fibrosis (CF) benefit from beta-Carotene supplementation for 6 months. In: 22nd European Cystic Fibrosis Conference; 1998 June 13-19; Berlin, Germany. 1998:97. [CENTRAL: 794967] [CFGD REGISTER: GN69b] RustP , EichlerI , ElmadfaI . Influence of an oral beta-carotine-supplementation on the antioxidant status of patients with cystic fibrosis [Einfluss einer oralen beta-Karotin-Supplementierung auf den Antioxidantienstatus von Patienten mit zystischer Fibrose]. Atemwegs und Lungenkrankheiten1997;23:51. [CENTRAL: 255854] [CFGD REGISTER: GN69d] RustP , EichlerI , RennerS , ElmadfaI . Effects of long-term oral beta-carotene supplementation on lipid peroxidation in patients with cystic fibrosis. International Journal for Vitamin and Nutrition Research1998;68(2):83-7. [CENTRAL: 208549] [CFGD REGISTER: GN69c] [PMID: 9565821]RustP , EichlerI , RennerS , ElmadfaI . Long-term oral beta-carotene supplementation in patients with cystic fibrosis - effects on antioxidative status and pulmonary function. Annals of Nutrition &amp; Metabolism2000;44(1):30-7. [CENTRAL: 297191] [CFGD REGISTER: GN69e] [PMID: 10838464]">Rust 1998</a>). </p> </section> <section id="CD006751-sec-0058"> <h6 class="title">2. Growth and nutritional status</h6> <section id="CD006751-sec-0059"> <p><b>a. weight</b></p> <p>No separate analysable weight data were reported.</p> </section> <section id="CD006751-sec-0060"> <p><b>b. height</b></p> <p>After 24 weeks of β‐carotene supplementation (12 weeks at a high dose followed by 12 weeks at a low dose), there was no statistical significant difference in the z score for height between the supplementation and the placebo groups, MD ‐0.23 (95% CI ‐0.89 to 0.43) (low‐quality evidence) (<a href="./references#CD006751-fig-0003" title="">Analysis 1.1</a>). </p> </section> <section id="CD006751-sec-0061"> <p><b>c. BMI</b></p> <p>Additionally, the authors reported no significant group differences or time‐trends for measurements of BMI. No data were reported post high‐dose supplementation. Quantitative data on BMI were requested but not available. </p> </section> </section> <section id="CD006751-sec-0062"> <h6 class="title">3. Mortality</h6> <p>The included study did not report on mortality (<a href="./references#CD006751-bbs2-0001" title="EnglB , RustP , EichlerI , RennerS , ElmadfaI . Bioavailability of therapeutic Beta-Carotine (BC) in patients with cystic fibrosis (CF) and effects on anthropometrical parameters over 6 months [Bioverfugbarkeit einer therapeutischen Beta-Carotin (BC) Gabe bei Patienten mit zystischer Fibrose (CF) und Auswirkungen auf anthropometrische Parameter uber eine Versuchsdauer von 6 Monaten]. Monatsschrift fur Kinderheilkunde1997;145:S 134. [CENTRAL: 336058] [CFGD REGISTER: GN69g] RennerS , RathR , RustP , LehrS , FrischerT , ElmadfaI , et al. Effects of beta-carotene supplementation for six months on clinical and laboratory parameters in patients with cystic fibrosis. Thorax2001;56(1):48-52. [CENTRAL: 329478] [CFGD REGISTER: GN69f] [PMID: 11120904]RennerS , WojnarowskiC , KollerDY , RustP , ElmadfaI , EichlerI . Patients with cystic fibrosis (CF) benefit from β-carotene supplementation for 6 months. Pediatric Pulmonology1997;Suppl 14:314. [CENTRAL: 794966] [CFGD REGISTER: GN69a] RennerS , WojnarowskiC , KollerDY , RustP , ElmadfaI , EichlerI . Patients with cystic fibrosis (CF) benefit from beta-Carotene supplementation for 6 months. In: 22nd European Cystic Fibrosis Conference; 1998 June 13-19; Berlin, Germany. 1998:97. [CENTRAL: 794967] [CFGD REGISTER: GN69b] RustP , EichlerI , ElmadfaI . Influence of an oral beta-carotine-supplementation on the antioxidant status of patients with cystic fibrosis [Einfluss einer oralen beta-Karotin-Supplementierung auf den Antioxidantienstatus von Patienten mit zystischer Fibrose]. Atemwegs und Lungenkrankheiten1997;23:51. [CENTRAL: 255854] [CFGD REGISTER: GN69d] RustP , EichlerI , RennerS , ElmadfaI . Effects of long-term oral beta-carotene supplementation on lipid peroxidation in patients with cystic fibrosis. International Journal for Vitamin and Nutrition Research1998;68(2):83-7. [CENTRAL: 208549] [CFGD REGISTER: GN69c] [PMID: 9565821]RustP , EichlerI , RennerS , ElmadfaI . Long-term oral beta-carotene supplementation in patients with cystic fibrosis - effects on antioxidative status and pulmonary function. Annals of Nutrition &amp; Metabolism2000;44(1):30-7. [CENTRAL: 297191] [CFGD REGISTER: GN69e] [PMID: 10838464]">Rust 1998</a>). </p> </section> </section> <section id="CD006751-sec-0063"> <h5 class="title">Secondary outcomes</h5> <section id="CD006751-sec-0064"> <h6 class="title">1. Respiratory outcomes</h6> <section id="CD006751-sec-0065"> <p><b>a. Bronchiectasis severity control</b></p> <p>The included study did not report on bronchiectasis severity control (<a href="./references#CD006751-bbs2-0001" title="EnglB , RustP , EichlerI , RennerS , ElmadfaI . Bioavailability of therapeutic Beta-Carotine (BC) in patients with cystic fibrosis (CF) and effects on anthropometrical parameters over 6 months [Bioverfugbarkeit einer therapeutischen Beta-Carotin (BC) Gabe bei Patienten mit zystischer Fibrose (CF) und Auswirkungen auf anthropometrische Parameter uber eine Versuchsdauer von 6 Monaten]. Monatsschrift fur Kinderheilkunde1997;145:S 134. [CENTRAL: 336058] [CFGD REGISTER: GN69g] RennerS , RathR , RustP , LehrS , FrischerT , ElmadfaI , et al. Effects of beta-carotene supplementation for six months on clinical and laboratory parameters in patients with cystic fibrosis. Thorax2001;56(1):48-52. [CENTRAL: 329478] [CFGD REGISTER: GN69f] [PMID: 11120904]RennerS , WojnarowskiC , KollerDY , RustP , ElmadfaI , EichlerI . Patients with cystic fibrosis (CF) benefit from β-carotene supplementation for 6 months. Pediatric Pulmonology1997;Suppl 14:314. [CENTRAL: 794966] [CFGD REGISTER: GN69a] RennerS , WojnarowskiC , KollerDY , RustP , ElmadfaI , EichlerI . Patients with cystic fibrosis (CF) benefit from beta-Carotene supplementation for 6 months. In: 22nd European Cystic Fibrosis Conference; 1998 June 13-19; Berlin, Germany. 1998:97. [CENTRAL: 794967] [CFGD REGISTER: GN69b] RustP , EichlerI , ElmadfaI . Influence of an oral beta-carotine-supplementation on the antioxidant status of patients with cystic fibrosis [Einfluss einer oralen beta-Karotin-Supplementierung auf den Antioxidantienstatus von Patienten mit zystischer Fibrose]. Atemwegs und Lungenkrankheiten1997;23:51. [CENTRAL: 255854] [CFGD REGISTER: GN69d] RustP , EichlerI , RennerS , ElmadfaI . Effects of long-term oral beta-carotene supplementation on lipid peroxidation in patients with cystic fibrosis. International Journal for Vitamin and Nutrition Research1998;68(2):83-7. [CENTRAL: 208549] [CFGD REGISTER: GN69c] [PMID: 9565821]RustP , EichlerI , RennerS , ElmadfaI . Long-term oral beta-carotene supplementation in patients with cystic fibrosis - effects on antioxidative status and pulmonary function. Annals of Nutrition &amp; Metabolism2000;44(1):30-7. [CENTRAL: 297191] [CFGD REGISTER: GN69e] [PMID: 10838464]">Rust 1998</a>). </p> </section> <section id="CD006751-sec-0066"> <p><b>b. Lung function indices</b></p> <p>i. FEV<sub>1</sub> </p> <p>No statistical significant difference in FEV<sub>1</sub> (% predicted) was observed between the β‐carotene supplementation and the placebo groups at either three months (post high dose), MD ‐10.6% (95% CI ‐31.1 to 9.9) or six months (post low dose), MD ‐10.3% (95%CI ‐31.6 to 110.0), both results judged to be low‐quality evidence (<a href="./references#CD006751-fig-0004" title="">Analysis 1.2</a>). </p> <p>ii. FVC</p> <p>The included study did not report on FVC (<a href="./references#CD006751-bbs2-0001" title="EnglB , RustP , EichlerI , RennerS , ElmadfaI . Bioavailability of therapeutic Beta-Carotine (BC) in patients with cystic fibrosis (CF) and effects on anthropometrical parameters over 6 months [Bioverfugbarkeit einer therapeutischen Beta-Carotin (BC) Gabe bei Patienten mit zystischer Fibrose (CF) und Auswirkungen auf anthropometrische Parameter uber eine Versuchsdauer von 6 Monaten]. Monatsschrift fur Kinderheilkunde1997;145:S 134. [CENTRAL: 336058] [CFGD REGISTER: GN69g] RennerS , RathR , RustP , LehrS , FrischerT , ElmadfaI , et al. Effects of beta-carotene supplementation for six months on clinical and laboratory parameters in patients with cystic fibrosis. Thorax2001;56(1):48-52. [CENTRAL: 329478] [CFGD REGISTER: GN69f] [PMID: 11120904]RennerS , WojnarowskiC , KollerDY , RustP , ElmadfaI , EichlerI . Patients with cystic fibrosis (CF) benefit from β-carotene supplementation for 6 months. Pediatric Pulmonology1997;Suppl 14:314. [CENTRAL: 794966] [CFGD REGISTER: GN69a] RennerS , WojnarowskiC , KollerDY , RustP , ElmadfaI , EichlerI . Patients with cystic fibrosis (CF) benefit from beta-Carotene supplementation for 6 months. In: 22nd European Cystic Fibrosis Conference; 1998 June 13-19; Berlin, Germany. 1998:97. [CENTRAL: 794967] [CFGD REGISTER: GN69b] RustP , EichlerI , ElmadfaI . Influence of an oral beta-carotine-supplementation on the antioxidant status of patients with cystic fibrosis [Einfluss einer oralen beta-Karotin-Supplementierung auf den Antioxidantienstatus von Patienten mit zystischer Fibrose]. Atemwegs und Lungenkrankheiten1997;23:51. [CENTRAL: 255854] [CFGD REGISTER: GN69d] RustP , EichlerI , RennerS , ElmadfaI . Effects of long-term oral beta-carotene supplementation on lipid peroxidation in patients with cystic fibrosis. International Journal for Vitamin and Nutrition Research1998;68(2):83-7. [CENTRAL: 208549] [CFGD REGISTER: GN69c] [PMID: 9565821]RustP , EichlerI , RennerS , ElmadfaI . Long-term oral beta-carotene supplementation in patients with cystic fibrosis - effects on antioxidative status and pulmonary function. Annals of Nutrition &amp; Metabolism2000;44(1):30-7. [CENTRAL: 297191] [CFGD REGISTER: GN69e] [PMID: 10838464]">Rust 1998</a>). </p> </section> <section id="CD006751-sec-0067"> <p><b>c. Proportions of participants who had respiratory exacerbations or hospitalisations or both</b></p> <p>The included study measured this outcome in terms of the number of days per person on which systemic antibiotics were used in three‐month blocks (three months prior to baseline, baseline to three months and three months to six months). At three months (post high dose β‐carotene supplementation) a statistical significant difference was observed between the supplementation group and the placebo group, MD ‐15.00 days (95% CI ‐27.60 to ‐2.40) (low‐quality evidence) (<a href="./references#CD006751-fig-0005" title="">Analysis 1.3</a>). This effect was not maintained during the low‐dose supplementation, as seen at the six‐month time‐point, which should be interpreted carefully since for this outcome a carry‐over effect would have been present, MD ‐8.00 days (95% CI ‐18.80 to 2.80) (low‐quality evidence). </p> </section> <section id="CD006751-sec-0068"> <p><b>d. Total number of hospitalised days or days off work or school</b></p> <p>The included study did not report on the number of hospitalised days or days off work or school (<a href="./references#CD006751-bbs2-0001" title="EnglB , RustP , EichlerI , RennerS , ElmadfaI . Bioavailability of therapeutic Beta-Carotine (BC) in patients with cystic fibrosis (CF) and effects on anthropometrical parameters over 6 months [Bioverfugbarkeit einer therapeutischen Beta-Carotin (BC) Gabe bei Patienten mit zystischer Fibrose (CF) und Auswirkungen auf anthropometrische Parameter uber eine Versuchsdauer von 6 Monaten]. Monatsschrift fur Kinderheilkunde1997;145:S 134. [CENTRAL: 336058] [CFGD REGISTER: GN69g] RennerS , RathR , RustP , LehrS , FrischerT , ElmadfaI , et al. Effects of beta-carotene supplementation for six months on clinical and laboratory parameters in patients with cystic fibrosis. Thorax2001;56(1):48-52. [CENTRAL: 329478] [CFGD REGISTER: GN69f] [PMID: 11120904]RennerS , WojnarowskiC , KollerDY , RustP , ElmadfaI , EichlerI . Patients with cystic fibrosis (CF) benefit from β-carotene supplementation for 6 months. Pediatric Pulmonology1997;Suppl 14:314. [CENTRAL: 794966] [CFGD REGISTER: GN69a] RennerS , WojnarowskiC , KollerDY , RustP , ElmadfaI , EichlerI . Patients with cystic fibrosis (CF) benefit from beta-Carotene supplementation for 6 months. In: 22nd European Cystic Fibrosis Conference; 1998 June 13-19; Berlin, Germany. 1998:97. [CENTRAL: 794967] [CFGD REGISTER: GN69b] RustP , EichlerI , ElmadfaI . Influence of an oral beta-carotine-supplementation on the antioxidant status of patients with cystic fibrosis [Einfluss einer oralen beta-Karotin-Supplementierung auf den Antioxidantienstatus von Patienten mit zystischer Fibrose]. Atemwegs und Lungenkrankheiten1997;23:51. [CENTRAL: 255854] [CFGD REGISTER: GN69d] RustP , EichlerI , RennerS , ElmadfaI . Effects of long-term oral beta-carotene supplementation on lipid peroxidation in patients with cystic fibrosis. International Journal for Vitamin and Nutrition Research1998;68(2):83-7. [CENTRAL: 208549] [CFGD REGISTER: GN69c] [PMID: 9565821]RustP , EichlerI , RennerS , ElmadfaI . Long-term oral beta-carotene supplementation in patients with cystic fibrosis - effects on antioxidative status and pulmonary function. Annals of Nutrition &amp; Metabolism2000;44(1):30-7. [CENTRAL: 297191] [CFGD REGISTER: GN69e] [PMID: 10838464]">Rust 1998</a>). </p> </section> </section> <section id="CD006751-sec-0069"> <h6 class="title">2. Quality of life</h6> <p>The included study did not report on quality of life (<a href="./references#CD006751-bbs2-0001" title="EnglB , RustP , EichlerI , RennerS , ElmadfaI . Bioavailability of therapeutic Beta-Carotine (BC) in patients with cystic fibrosis (CF) and effects on anthropometrical parameters over 6 months [Bioverfugbarkeit einer therapeutischen Beta-Carotin (BC) Gabe bei Patienten mit zystischer Fibrose (CF) und Auswirkungen auf anthropometrische Parameter uber eine Versuchsdauer von 6 Monaten]. Monatsschrift fur Kinderheilkunde1997;145:S 134. [CENTRAL: 336058] [CFGD REGISTER: GN69g] RennerS , RathR , RustP , LehrS , FrischerT , ElmadfaI , et al. Effects of beta-carotene supplementation for six months on clinical and laboratory parameters in patients with cystic fibrosis. Thorax2001;56(1):48-52. [CENTRAL: 329478] [CFGD REGISTER: GN69f] [PMID: 11120904]RennerS , WojnarowskiC , KollerDY , RustP , ElmadfaI , EichlerI . Patients with cystic fibrosis (CF) benefit from β-carotene supplementation for 6 months. Pediatric Pulmonology1997;Suppl 14:314. [CENTRAL: 794966] [CFGD REGISTER: GN69a] RennerS , WojnarowskiC , KollerDY , RustP , ElmadfaI , EichlerI . Patients with cystic fibrosis (CF) benefit from beta-Carotene supplementation for 6 months. In: 22nd European Cystic Fibrosis Conference; 1998 June 13-19; Berlin, Germany. 1998:97. [CENTRAL: 794967] [CFGD REGISTER: GN69b] RustP , EichlerI , ElmadfaI . Influence of an oral beta-carotine-supplementation on the antioxidant status of patients with cystic fibrosis [Einfluss einer oralen beta-Karotin-Supplementierung auf den Antioxidantienstatus von Patienten mit zystischer Fibrose]. Atemwegs und Lungenkrankheiten1997;23:51. [CENTRAL: 255854] [CFGD REGISTER: GN69d] RustP , EichlerI , RennerS , ElmadfaI . Effects of long-term oral beta-carotene supplementation on lipid peroxidation in patients with cystic fibrosis. International Journal for Vitamin and Nutrition Research1998;68(2):83-7. [CENTRAL: 208549] [CFGD REGISTER: GN69c] [PMID: 9565821]RustP , EichlerI , RennerS , ElmadfaI . Long-term oral beta-carotene supplementation in patients with cystic fibrosis - effects on antioxidative status and pulmonary function. Annals of Nutrition &amp; Metabolism2000;44(1):30-7. [CENTRAL: 297191] [CFGD REGISTER: GN69e] [PMID: 10838464]">Rust 1998</a>). </p> </section> <section id="CD006751-sec-0070"> <h6 class="title">3. Adverse events</h6> <p>In the included study, the authors reported that no adverse events were observed (low‐quality evidence) (<a href="./references#CD006751-bbs2-0001" title="EnglB , RustP , EichlerI , RennerS , ElmadfaI . Bioavailability of therapeutic Beta-Carotine (BC) in patients with cystic fibrosis (CF) and effects on anthropometrical parameters over 6 months [Bioverfugbarkeit einer therapeutischen Beta-Carotin (BC) Gabe bei Patienten mit zystischer Fibrose (CF) und Auswirkungen auf anthropometrische Parameter uber eine Versuchsdauer von 6 Monaten]. Monatsschrift fur Kinderheilkunde1997;145:S 134. [CENTRAL: 336058] [CFGD REGISTER: GN69g] RennerS , RathR , RustP , LehrS , FrischerT , ElmadfaI , et al. Effects of beta-carotene supplementation for six months on clinical and laboratory parameters in patients with cystic fibrosis. Thorax2001;56(1):48-52. [CENTRAL: 329478] [CFGD REGISTER: GN69f] [PMID: 11120904]RennerS , WojnarowskiC , KollerDY , RustP , ElmadfaI , EichlerI . Patients with cystic fibrosis (CF) benefit from β-carotene supplementation for 6 months. Pediatric Pulmonology1997;Suppl 14:314. [CENTRAL: 794966] [CFGD REGISTER: GN69a] RennerS , WojnarowskiC , KollerDY , RustP , ElmadfaI , EichlerI . Patients with cystic fibrosis (CF) benefit from beta-Carotene supplementation for 6 months. In: 22nd European Cystic Fibrosis Conference; 1998 June 13-19; Berlin, Germany. 1998:97. [CENTRAL: 794967] [CFGD REGISTER: GN69b] RustP , EichlerI , ElmadfaI . Influence of an oral beta-carotine-supplementation on the antioxidant status of patients with cystic fibrosis [Einfluss einer oralen beta-Karotin-Supplementierung auf den Antioxidantienstatus von Patienten mit zystischer Fibrose]. Atemwegs und Lungenkrankheiten1997;23:51. [CENTRAL: 255854] [CFGD REGISTER: GN69d] RustP , EichlerI , RennerS , ElmadfaI . Effects of long-term oral beta-carotene supplementation on lipid peroxidation in patients with cystic fibrosis. International Journal for Vitamin and Nutrition Research1998;68(2):83-7. [CENTRAL: 208549] [CFGD REGISTER: GN69c] [PMID: 9565821]RustP , EichlerI , RennerS , ElmadfaI . Long-term oral beta-carotene supplementation in patients with cystic fibrosis - effects on antioxidative status and pulmonary function. Annals of Nutrition &amp; Metabolism2000;44(1):30-7. [CENTRAL: 297191] [CFGD REGISTER: GN69e] [PMID: 10838464]">Rust 1998</a>). </p> </section> <section id="CD006751-sec-0071"> <h6 class="title">4. Possible toxicity events</h6> <p>The included study did not report on any toxicity events, although the authors stated that no risk of vitamin A toxicity could be detected since vitamin A plasma levels stayed in the lower normal range during the entire study (<a href="./references#CD006751-bbs2-0001" title="EnglB , RustP , EichlerI , RennerS , ElmadfaI . Bioavailability of therapeutic Beta-Carotine (BC) in patients with cystic fibrosis (CF) and effects on anthropometrical parameters over 6 months [Bioverfugbarkeit einer therapeutischen Beta-Carotin (BC) Gabe bei Patienten mit zystischer Fibrose (CF) und Auswirkungen auf anthropometrische Parameter uber eine Versuchsdauer von 6 Monaten]. Monatsschrift fur Kinderheilkunde1997;145:S 134. [CENTRAL: 336058] [CFGD REGISTER: GN69g] RennerS , RathR , RustP , LehrS , FrischerT , ElmadfaI , et al. Effects of beta-carotene supplementation for six months on clinical and laboratory parameters in patients with cystic fibrosis. Thorax2001;56(1):48-52. [CENTRAL: 329478] [CFGD REGISTER: GN69f] [PMID: 11120904]RennerS , WojnarowskiC , KollerDY , RustP , ElmadfaI , EichlerI . Patients with cystic fibrosis (CF) benefit from β-carotene supplementation for 6 months. Pediatric Pulmonology1997;Suppl 14:314. [CENTRAL: 794966] [CFGD REGISTER: GN69a] RennerS , WojnarowskiC , KollerDY , RustP , ElmadfaI , EichlerI . Patients with cystic fibrosis (CF) benefit from beta-Carotene supplementation for 6 months. In: 22nd European Cystic Fibrosis Conference; 1998 June 13-19; Berlin, Germany. 1998:97. [CENTRAL: 794967] [CFGD REGISTER: GN69b] RustP , EichlerI , ElmadfaI . Influence of an oral beta-carotine-supplementation on the antioxidant status of patients with cystic fibrosis [Einfluss einer oralen beta-Karotin-Supplementierung auf den Antioxidantienstatus von Patienten mit zystischer Fibrose]. Atemwegs und Lungenkrankheiten1997;23:51. [CENTRAL: 255854] [CFGD REGISTER: GN69d] RustP , EichlerI , RennerS , ElmadfaI . Effects of long-term oral beta-carotene supplementation on lipid peroxidation in patients with cystic fibrosis. International Journal for Vitamin and Nutrition Research1998;68(2):83-7. [CENTRAL: 208549] [CFGD REGISTER: GN69c] [PMID: 9565821]RustP , EichlerI , RennerS , ElmadfaI . Long-term oral beta-carotene supplementation in patients with cystic fibrosis - effects on antioxidative status and pulmonary function. Annals of Nutrition &amp; Metabolism2000;44(1):30-7. [CENTRAL: 297191] [CFGD REGISTER: GN69e] [PMID: 10838464]">Rust 1998</a>). </p> </section> <section id="CD006751-sec-0072"> <h6 class="title">5. Measured levels of vitamin A, carotenes or other retinoids (or both)</h6> <p>Data showed that β‐carotene supplementation did not seem to affect vitamin A plasma levels post high‐dose supplementation, MD ‐0.10 µmol/L (95% CI ‐0.31 to 0.11) and minimal post low‐dose supplementation, MD 0.20 µmol/L (95% 0.04 to 0.36) (<a href="./references#CD006751-fig-0006" title="">Analysis 1.4</a>). Plasma levels of β‐carotene were significantly higher following high‐dose β‐carotene supplementation compared to levels in the placebo group, MD 0.49 µmol/L (95% CI 0.28 to 0.70) (<a href="./references#CD006751-fig-0007" title="">Analysis 1.5</a>). This effect was partly sustained at the end of the following three‐month low‐dose supplementation, MD 0.26 µmol/L (95% CI 0.15 to 0.37) (<a href="./references#CD006751-fig-0007" title="">Analysis 1.5</a>). Although discrepancies between the different papers from this study on the reported β‐carotene plasma levels after four weeks have been identified, no discrepancies in measured levels at the endpoints were observed. </p> </section> </section> </section> <section id="CD006751-sec-0073"> <h4 class="title">Other retinoid supplementation</h4> <p>No studies on other retinoid supplementation were eligible for inclusion.</p> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD006751-sec-0074" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD006751-sec-0074"></div> <section id="CD006751-sec-0075"> <h3 class="title" id="CD006751-sec-0075">Summary of main results</h3> <p>In this updated review, there were no studies on vitamin A or other retinoid supplementation for people with CF eligible for inclusion. A single study on β‐carotene supplementation included at the 2018 update showed positive effects on some of the defined outcome measures for this review (<a href="./references#CD006751-bbs2-0001" title="EnglB , RustP , EichlerI , RennerS , ElmadfaI . Bioavailability of therapeutic Beta-Carotine (BC) in patients with cystic fibrosis (CF) and effects on anthropometrical parameters over 6 months [Bioverfugbarkeit einer therapeutischen Beta-Carotin (BC) Gabe bei Patienten mit zystischer Fibrose (CF) und Auswirkungen auf anthropometrische Parameter uber eine Versuchsdauer von 6 Monaten]. Monatsschrift fur Kinderheilkunde1997;145:S 134. [CENTRAL: 336058] [CFGD REGISTER: GN69g] RennerS , RathR , RustP , LehrS , FrischerT , ElmadfaI , et al. Effects of beta-carotene supplementation for six months on clinical and laboratory parameters in patients with cystic fibrosis. Thorax2001;56(1):48-52. [CENTRAL: 329478] [CFGD REGISTER: GN69f] [PMID: 11120904]RennerS , WojnarowskiC , KollerDY , RustP , ElmadfaI , EichlerI . Patients with cystic fibrosis (CF) benefit from β-carotene supplementation for 6 months. Pediatric Pulmonology1997;Suppl 14:314. [CENTRAL: 794966] [CFGD REGISTER: GN69a] RennerS , WojnarowskiC , KollerDY , RustP , ElmadfaI , EichlerI . Patients with cystic fibrosis (CF) benefit from beta-Carotene supplementation for 6 months. In: 22nd European Cystic Fibrosis Conference; 1998 June 13-19; Berlin, Germany. 1998:97. [CENTRAL: 794967] [CFGD REGISTER: GN69b] RustP , EichlerI , ElmadfaI . Influence of an oral beta-carotine-supplementation on the antioxidant status of patients with cystic fibrosis [Einfluss einer oralen beta-Karotin-Supplementierung auf den Antioxidantienstatus von Patienten mit zystischer Fibrose]. Atemwegs und Lungenkrankheiten1997;23:51. [CENTRAL: 255854] [CFGD REGISTER: GN69d] RustP , EichlerI , RennerS , ElmadfaI . Effects of long-term oral beta-carotene supplementation on lipid peroxidation in patients with cystic fibrosis. International Journal for Vitamin and Nutrition Research1998;68(2):83-7. [CENTRAL: 208549] [CFGD REGISTER: GN69c] [PMID: 9565821]RustP , EichlerI , RennerS , ElmadfaI . Long-term oral beta-carotene supplementation in patients with cystic fibrosis - effects on antioxidative status and pulmonary function. Annals of Nutrition &amp; Metabolism2000;44(1):30-7. [CENTRAL: 297191] [CFGD REGISTER: GN69e] [PMID: 10838464]">Rust 1998</a>). However, the strength of evidence for this included study is considered low (<a href="./full#CD006751-tbl-0001">summary of findings Table 1</a>) (<a href="#CD006751-fig-0002">Figure 2</a>), mainly due to study design, unclear description of methods and outcome reporting, and small study population. Nevertheless, the study found that with high‐dose β‐carotene supplementation significantly fewer days of systemic antibiotics were required for treating pulmonary exacerbations compared to controls, a finding that was not sustained during low‐dose supplementation. In addition, as one would expect, β‐carotene supplementation resulted in higher β‐carotene plasma levels. No statistically significant effect on any other clinical outcome measures was shown. </p> </section> <section id="CD006751-sec-0076"> <h3 class="title" id="CD006751-sec-0076">Overall completeness and applicability of evidence</h3> <p>It is well accepted that people with CF and pancreatic insufficiency are at risk of vitamin A deficiency. However, this is now a rare occurrence (<a href="./references#CD006751-bbs2-0009" title="BreiC , SimonA , KrawinkelMB , NaehrlichL . Individualized vitamin A supplementation for patients with cystic fibrosis. Clinical Nutrition (Edinburgh, Scotland)2013;32(5):805-10. [DOI: 10.1016/j.clnu.2013.01.009] [PMID: 23395254]">Brei 2013</a>). It is also biologically plausible that currently, with improved pancreatic replacement therapies and attention to macronutrition and caloric supplements, the majority of people with CF are vitamin A sufficient and may not require daily vitamin A supplementation. Despite this, daily vitamin A supplementation is almost universally recommended for people with CF who are pancreatic insufficient (<a href="./references#CD006751-bbs2-0023" title="Graham-MaarRC , SchallJI , StettlerN , ZemelBS , StallingsVA . Elevated vitamin A intake and serum retinol in preadolescent children with cystic fibrosis. American Journal of Clinical Nutrition2006;84(1):174-82. [PMID: 16825693]">Graham‐Maar 2006</a>; <a href="./references#CD006751-bbs2-0041" title="Clinical Guidelines: Care of Children with Cystic Fibrosis: Royal Brompton Hospital (7th edition) 2017. www.rbht.nhs.uk/childrencf (accessed 07 February 2017).">Royal Brompton Hospital 2017</a>; <a href="./references#CD006751-bbs2-0042" title="SaxbyN , PainterC , KenchA , KingS , CrowderT , van derHaakN , et al. Nutrition Guidelines for Cystic Fibrosis in Australia and New Zealand. Thoracic Society of Australia and New Zealand https://www.thoracic.org.au/documents/item/1045 (accessed 16 January 2018).">Saxby 2017</a>). Whether or not there is a beneficial or harmful effect of this vitamin A supplementation in people with CF remains unknown. Since no studies of vitamin A supplementation were included in this review, no conclusions regarding vitamin A supplementation can be made. </p> <p>Supplementation with β‐carotene is currently not recommended in people with CF (<a href="./references#CD006751-bbs2-0042" title="SaxbyN , PainterC , KenchA , KingS , CrowderT , van derHaakN , et al. Nutrition Guidelines for Cystic Fibrosis in Australia and New Zealand. Thoracic Society of Australia and New Zealand https://www.thoracic.org.au/documents/item/1045 (accessed 16 January 2018).">Saxby 2017</a>); no convincing evidence of clinical benefit from β‐carotene supplementation in people with CF was demonstrated; a conclusion shared by Ciofu and colleagues, who reviewed antioxidant supplementation, including β‐carotene supplementation, in people with CF (<a href="./references#CD006751-bbs2-0016" title="CiofuO , LykkesfeldtJ . Antioxidant supplementation for lung disease in cystic fibrosis. Cochrane Database of Systematic Reviews2014, Issue 8. [DOI: 10.1002/14651858.CD007020.pub3] [PMID: 25102015]">Ciofu 2014</a>). Although the authors of the included study recommend routine β‐carotene supplementation in people with CF, the results of our data analysis do not convincingly support this. It has been shown that β‐carotene supplementation is effective in correcting imbalance of markers of oxidative stress in people with CF, yet the clinical benefit of this correction has not been proven (<a href="./references#CD006751-bbs2-0022" title="GalliF , BattistoniA , GambariR , PompellaA , BragonziA , PilolliF , et al. Oxidative stress and antioxidant therapy in cystic fibrosis. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease2012;1822(5):690-713. [DOI: 10.1016/j.bbadis.2011.12.012] [PMID: 22226887]">Galli 2012</a>). </p> <p>Since no studies of other retinoid supplementation were included in this review, no conclusions regarding these supplements can be made. </p> <p>A potential limitation is the fact that oxidative stress parameters are not included in the outcome measures (see <a href="#CD006751-sec-0020">Types of outcome measures</a>). Although β‐carotene supplementation, a known antioxidant, is included, other oxidative stress markers (e.g. lipid peroxidation products and trolox equivalent antioxidative capacity) are not included. This decision was deliberate as plasma antioxidant status, and hence oxidative stress markers, are not directly related to improvement in clinical important outcome measures in CF (<a href="./references#CD006751-bbs2-0016" title="CiofuO , LykkesfeldtJ . Antioxidant supplementation for lung disease in cystic fibrosis. Cochrane Database of Systematic Reviews2014, Issue 8. [DOI: 10.1002/14651858.CD007020.pub3] [PMID: 25102015]">Ciofu 2014</a>; <a href="./references#CD006751-bbs2-0022" title="GalliF , BattistoniA , GambariR , PompellaA , BragonziA , PilolliF , et al. Oxidative stress and antioxidant therapy in cystic fibrosis. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease2012;1822(5):690-713. [DOI: 10.1016/j.bbadis.2011.12.012] [PMID: 22226887]">Galli 2012</a>). </p> <p>In summary, this updated Cochrane Review has added results from one small single‐centre study (<a href="./references#CD006751-bbs2-0001" title="EnglB , RustP , EichlerI , RennerS , ElmadfaI . Bioavailability of therapeutic Beta-Carotine (BC) in patients with cystic fibrosis (CF) and effects on anthropometrical parameters over 6 months [Bioverfugbarkeit einer therapeutischen Beta-Carotin (BC) Gabe bei Patienten mit zystischer Fibrose (CF) und Auswirkungen auf anthropometrische Parameter uber eine Versuchsdauer von 6 Monaten]. Monatsschrift fur Kinderheilkunde1997;145:S 134. [CENTRAL: 336058] [CFGD REGISTER: GN69g] RennerS , RathR , RustP , LehrS , FrischerT , ElmadfaI , et al. Effects of beta-carotene supplementation for six months on clinical and laboratory parameters in patients with cystic fibrosis. Thorax2001;56(1):48-52. [CENTRAL: 329478] [CFGD REGISTER: GN69f] [PMID: 11120904]RennerS , WojnarowskiC , KollerDY , RustP , ElmadfaI , EichlerI . Patients with cystic fibrosis (CF) benefit from β-carotene supplementation for 6 months. Pediatric Pulmonology1997;Suppl 14:314. [CENTRAL: 794966] [CFGD REGISTER: GN69a] RennerS , WojnarowskiC , KollerDY , RustP , ElmadfaI , EichlerI . Patients with cystic fibrosis (CF) benefit from beta-Carotene supplementation for 6 months. In: 22nd European Cystic Fibrosis Conference; 1998 June 13-19; Berlin, Germany. 1998:97. [CENTRAL: 794967] [CFGD REGISTER: GN69b] RustP , EichlerI , ElmadfaI . Influence of an oral beta-carotine-supplementation on the antioxidant status of patients with cystic fibrosis [Einfluss einer oralen beta-Karotin-Supplementierung auf den Antioxidantienstatus von Patienten mit zystischer Fibrose]. Atemwegs und Lungenkrankheiten1997;23:51. [CENTRAL: 255854] [CFGD REGISTER: GN69d] RustP , EichlerI , RennerS , ElmadfaI . Effects of long-term oral beta-carotene supplementation on lipid peroxidation in patients with cystic fibrosis. International Journal for Vitamin and Nutrition Research1998;68(2):83-7. [CENTRAL: 208549] [CFGD REGISTER: GN69c] [PMID: 9565821]RustP , EichlerI , RennerS , ElmadfaI . Long-term oral beta-carotene supplementation in patients with cystic fibrosis - effects on antioxidative status and pulmonary function. Annals of Nutrition &amp; Metabolism2000;44(1):30-7. [CENTRAL: 297191] [CFGD REGISTER: GN69e] [PMID: 10838464]">Rust 1998</a>). There is an unclear risk of potential bias within the data, particularly for outcomes post low‐dose supplementation due to the study design. Hence, although data analysis partly supports supplementation in terms of need for antibiotics and plasma levels of β‐carotene, this review provides only limited evidence that β‐carotene supplementation in people with CF may be beneficial. </p> </section> <section id="CD006751-sec-0077"> <h3 class="title" id="CD006751-sec-0077">Quality of the evidence</h3> <p>With no studies on vitamin A or other retinoid supplementation eligible for inclusion and only one small study (n = 24) on β‐carotene supplementation included, the overall quality of the evidence is considered low. As described above in more detail, the included study was not free of bias, mainly due to its design and the unclear description of methods and outcome reporting. This is also reflected in the quality assessments for the evidence presented in the included study using the GRADE approach (<a href="./full#CD006751-tbl-0001">summary of findings Table 1</a>). Since the overall quality of the evidence is considered low, the ability to draw any robust conclusions on β‐carotene supplementation is limited. </p> </section> <section id="CD006751-sec-0078"> <h3 class="title" id="CD006751-sec-0078">Potential biases in the review process</h3> <p>To reduce potential biases, two authors (JM, JdV) assessed all potentially eligible studies individually. The data extraction and risk of bias assessments were also independently undertaken by the same two authors and when disagreement existed, an independent third author adjudicated (AC). No external potential sources of bias exist for any authors. </p> </section> <section id="CD006751-sec-0079"> <h3 class="title" id="CD006751-sec-0079">Agreements and disagreements with other studies or reviews</h3> <p>While vitamin A deficiency causes eye and skin disorders, excess vitamin A can also cause problems (<a href="./references#CD006751-bbs2-0024" title="GriffithsJK . The vitamin A paradox. Journal of Pediatrics2000;137(5):604-7. [PMID: 11060523]">Griffiths 2000</a>; <a href="./references#CD006751-bbs2-0039" title="PennistonKL , TanumihardjoSA . The acute and chronic toxic effects of vitamin A. American Journal of Clinical Nutrition2006;83(2):191-201. [PMID: 16469975]">Penniston 2006</a>). Indeed, increasingly data on micronutrients have shown that micronutrient supplementation is only beneficial in states of deficiency and harmful when no deficiency exists (<a href="./references#CD006751-bbs2-0015" title="ChangAB , TorzilloPJ , BoyceNC , WhiteAV , StewartPA , WheatonGR , et al. Zinc and vitamin A supplementation in Indigenous Australian children hospitalised with lower respiratory tract infection: a randomised controlled trial. Medical Journal of Australia2006;184(3):107-12. [PMID: 16460294]">Chang 2006</a>; <a href="./references#CD006751-bbs2-0044" title="ShenkinA . The key role of micronutrients. Clinical Nutrition2006;25(1):1-13. [DOI: 10.1016/j.clnu.2005.11.006] [PMID: 16376462]">Shenkin 2006</a>). For vitamin A, Griffiths has termed this the 'vitamin A paradox' as vitamin A supplementation is likely to be "protective against pneumonia in malnourished children (who are likely to be vitamin A‐deficient) and is paradoxically detrimental for adequately nourished children" (<a href="./references#CD006751-bbs2-0024" title="GriffithsJK . The vitamin A paradox. Journal of Pediatrics2000;137(5):604-7. [PMID: 11060523]">Griffiths 2000</a>). Vitamin A supplementation following current regimens leads to adequate intake levels of vitamin A, but levels exceeding the recommended upper level are not uncommon (<a href="./references#CD006751-bbs2-0009" title="BreiC , SimonA , KrawinkelMB , NaehrlichL . Individualized vitamin A supplementation for patients with cystic fibrosis. Clinical Nutrition (Edinburgh, Scotland)2013;32(5):805-10. [DOI: 10.1016/j.clnu.2013.01.009] [PMID: 23395254]">Brei 2013</a>; <a href="./references#CD006751-bbs2-0023" title="Graham-MaarRC , SchallJI , StettlerN , ZemelBS , StallingsVA . Elevated vitamin A intake and serum retinol in preadolescent children with cystic fibrosis. American Journal of Clinical Nutrition2006;84(1):174-82. [PMID: 16825693]">Graham‐Maar 2006</a>; <a href="./references#CD006751-bbs2-0032" title="LiL , SomersetS . Dietary intake and nutritional status of micronutrients in adults with cystic fibrosis in relation to current recommendations. Clinical Nutrition2016;35(4):775-82. [DOI: 10.1016/j.clnu.2015.06.004] [PMID: 26159903]">Li 2016</a>; <a href="./references#CD006751-bbs2-0033" title="MaqboolA , Graham-MaarRC , SchallJI , ZemelBS , StallingsVA . Vitamin A intake and elevated serum retinol levels in children and young adults with cystic fibrosis. Journal of Cystic Fibrosis2008;7(2):137-41. [DOI: 10.1016/j.jcf.2007.07.002] [PMID: 17766194]">Maqbool 2008</a>). Thus, some have called for individualised supplementation based on annual measurements rather than a fixed dosage, as is currently recommended in most CF guidelines (<a href="./references#CD006751-bbs2-0008" title="BorowitzD , BakerRD , StallingsV . Consensus report on nutrition for pediatric patients with cystic fibrosis. Journal of Pediatric Gastroenterology and Nutrition2002;35(3):246-59. [PMID: 12352509]">Borowitz 2002</a>; <a href="./references#CD006751-bbs2-0041" title="Clinical Guidelines: Care of Children with Cystic Fibrosis: Royal Brompton Hospital (7th edition) 2017. www.rbht.nhs.uk/childrencf (accessed 07 February 2017).">Royal Brompton Hospital 2017</a>; <a href="./references#CD006751-bbs2-0042" title="SaxbyN , PainterC , KenchA , KingS , CrowderT , van derHaakN , et al. Nutrition Guidelines for Cystic Fibrosis in Australia and New Zealand. Thoracic Society of Australia and New Zealand https://www.thoracic.org.au/documents/item/1045 (accessed 16 January 2018).">Saxby 2017</a>). </p> <p>Current guidelines do not specify whether the water‐soluble or the fat‐soluble form of retinol should be administered, but water‐soluble preparations present more risks of excess vitamin A levels to people with CF with pancreatic insufficiency, due to the easier absorption of the water‐soluble preparations compared to the fat‐soluble preparations (<a href="./references#CD006751-bbs2-0009" title="BreiC , SimonA , KrawinkelMB , NaehrlichL . Individualized vitamin A supplementation for patients with cystic fibrosis. Clinical Nutrition (Edinburgh, Scotland)2013;32(5):805-10. [DOI: 10.1016/j.clnu.2013.01.009] [PMID: 23395254]">Brei 2013</a>). Unfortunately, since no randomised clinical studies on vitamin A supplementation in CF were identified, the authors cannot draw any conclusions about the benefits of vitamin A supplementation in CF, nor whether supplementation should be administered as an individualised or a fixed dosage and whether this should be fat‐ or water‐soluble preparations. </p> <p>There is currently no recommendation for β‐carotene supplementation in people with CF (<a href="./references#CD006751-bbs2-0042" title="SaxbyN , PainterC , KenchA , KingS , CrowderT , van derHaakN , et al. Nutrition Guidelines for Cystic Fibrosis in Australia and New Zealand. Thoracic Society of Australia and New Zealand https://www.thoracic.org.au/documents/item/1045 (accessed 16 January 2018).">Saxby 2017</a>). A β‐carotene deficiency (either in CF or the general population) has not been defined, although it has been reported that children with CF display 9% to 24% of the normal serum carotenoid concentration and increased markers of oxidative stress (<a href="./references#CD006751-bbs2-0011" title="CantinAM , WhiteTB , CrossCE , FormanHJ , SokolRJ , BorowitzD . Antioxidants in cystic fibrosis. Conclusions from the CF Antioxidant Workshop, Bethesda, Maryland, November 11-12, 2003. Free Radical Biology and Medicine2007;42(1):15-31. [DOI: 10.1016/j.freeradbiomed.2006.09.022] [PMID: 17157190]">Cantin 2007</a>). The authors of a systematic review on antioxidant supplementation in CF, which also includes non‐randomised studies, concluded that normalizing β‐carotene concentrations is effective in correcting oxidative stress markers and is associated with minor clinical improvements (<a href="./references#CD006751-bbs2-0022" title="GalliF , BattistoniA , GambariR , PompellaA , BragonziA , PilolliF , et al. Oxidative stress and antioxidant therapy in cystic fibrosis. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease2012;1822(5):690-713. [DOI: 10.1016/j.bbadis.2011.12.012] [PMID: 22226887]">Galli 2012</a>). The Cochrane Review of antioxidant supplementation in CF found no positive treatment effect of any of the antioxidant micronutrients on any clinical outcomes (<a href="./references#CD006751-bbs2-0016" title="CiofuO , LykkesfeldtJ . Antioxidant supplementation for lung disease in cystic fibrosis. Cochrane Database of Systematic Reviews2014, Issue 8. [DOI: 10.1002/14651858.CD007020.pub3] [PMID: 25102015]">Ciofu 2014</a>). As they did not look at β‐carotene supplementation alone, no conclusions about its use can be made. </p> <p>Finally, it is not known whether supplementation with other retinoids is beneficial in children with CF or not. A randomised study showed that fenretinide supplementation corrects the inflammatory‐related imbalance between long chain and very long chain ceramides in CF compared to healthy controls within two weeks (<a href="./references#CD006751-bbs2-0003" title="GarićD , De SanctisJ , WojewodkaG , HouleD , CupriS , HajduchM , et al. Fenretinide differentially modulates the levels of long- and very long-chain ceramides by downregulating Cers5 enzyme: evidence from bench to bedside. Journal of Molecular Medicine (Berlin, Germany)2017;95(10):1053-64. GaricD , WojewodkaG , De SanctisJB , HajduchM , KoprivaF , PislariuR , et al. Fenretinide treatment increases long chain ceramide C24:0 and decreases short chain ceramide C16:0 levels in patients with cystic fibrosis (phase IB clinical trial). Pediatric pulmonology2015;50 Suppl 41:291. [ABSTRACT NO: 264] [CFGD REGISTER: GN253b] RadziochD , WojewodkaG , CupriS , ColinP , PislariuR , GarićD , et al. A novel oral formulation of fenretinide demonstrates safety and tolerability in a phase 1B dose-ascending trial involving adult cystic fibrosis patients. Pediatric Pulmonology2015;50 Suppl 41:290. [ABSTRACT NO: 261 ] [CFGD REGISTER: GN253c] WojewodkaG , MatoukE , De SanctisJB , PislariuR , ColinP , MatinC , et al. The cystic fibrosis associated fatty acid imbalance is corrected by a novel formulation of fenretinide in a phase 1B clinical trial. Pediatric Pulmonology2015;50 Suppl 41:289. [ABSTRACT NO: 260 ] [CFGD REGISTER: GN253a] ">Garić 2015</a>). So far no clinical outcomes have been reported, hence further research into fenretinide supplementation is needed to determine any clinical benefits. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD006751-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006751.pub5/media/CDSR/CD006751/urn:x-wiley:14651858:media:CD006751:CD006751-FIG-01" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram" data-id="CD006751-fig-0001" src="/cdsr/doi/10.1002/14651858.CD006751.pub5/media/CDSR/CD006751/image_n/nCD006751-FIG-01.png"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006751.pub5/media/CDSR/CD006751/image_t/tCD006751-FIG-01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006751.pub5/full#CD006751-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006751.pub5/media/CDSR/CD006751/image_n/nCD006751-FIG-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006751-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006751.pub5/media/CDSR/CD006751/urn:x-wiley:14651858:media:CD006751:CD006751-FIG-02" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for the included study." data-id="CD006751-fig-0002" src="/cdsr/doi/10.1002/14651858.CD006751.pub5/media/CDSR/CD006751/image_n/nCD006751-FIG-02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006751.pub5/media/CDSR/CD006751/image_t/tCD006751-FIG-02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for the included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006751.pub5/full#CD006751-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006751.pub5/media/CDSR/CD006751/image_n/nCD006751-FIG-02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006751-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006751.pub5/media/CDSR/CD006751/urn:x-wiley:14651858:media:CD006751:CD006751-CMP-001.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: β‐carotene supplementation versus placebo, Outcome 1: Growth and nutritional status: z score for height" data-id="CD006751-fig-0003" src="/cdsr/doi/10.1002/14651858.CD006751.pub5/media/CDSR/CD006751/image_n/nCD006751-CMP-001.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006751.pub5/media/CDSR/CD006751/image_t/tCD006751-CMP-001.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1: β‐carotene supplementation versus placebo, Outcome 1: Growth and nutritional status: z score for height </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006751.pub5/references#CD006751-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006751.pub5/media/CDSR/CD006751/image_n/nCD006751-CMP-001.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006751-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006751.pub5/media/CDSR/CD006751/urn:x-wiley:14651858:media:CD006751:CD006751-CMP-001.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: β‐carotene supplementation versus placebo, Outcome 2: Respiratory outcomes: FEV1 (% predicted)" data-id="CD006751-fig-0004" src="/cdsr/doi/10.1002/14651858.CD006751.pub5/media/CDSR/CD006751/image_n/nCD006751-CMP-001.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006751.pub5/media/CDSR/CD006751/image_t/tCD006751-CMP-001.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1: β‐carotene supplementation versus placebo, Outcome 2: Respiratory outcomes: FEV<sub>1</sub> (% predicted) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006751.pub5/references#CD006751-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006751.pub5/media/CDSR/CD006751/image_n/nCD006751-CMP-001.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006751-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006751.pub5/media/CDSR/CD006751/urn:x-wiley:14651858:media:CD006751:CD006751-CMP-001.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: β‐carotene supplementation versus placebo, Outcome 3: Respiratory outcomes: antibiotic days per patient in past 3 months" data-id="CD006751-fig-0005" src="/cdsr/doi/10.1002/14651858.CD006751.pub5/media/CDSR/CD006751/image_n/nCD006751-CMP-001.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006751.pub5/media/CDSR/CD006751/image_t/tCD006751-CMP-001.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1: β‐carotene supplementation versus placebo, Outcome 3: Respiratory outcomes: antibiotic days per patient in past 3 months </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006751.pub5/references#CD006751-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006751.pub5/media/CDSR/CD006751/image_n/nCD006751-CMP-001.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006751-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006751.pub5/media/CDSR/CD006751/urn:x-wiley:14651858:media:CD006751:CD006751-CMP-001.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: β‐carotene supplementation versus placebo, Outcome 4: Plasma concentrations: vitamin A [µmol/L]" data-id="CD006751-fig-0006" src="/cdsr/doi/10.1002/14651858.CD006751.pub5/media/CDSR/CD006751/image_n/nCD006751-CMP-001.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006751.pub5/media/CDSR/CD006751/image_t/tCD006751-CMP-001.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1: β‐carotene supplementation versus placebo, Outcome 4: Plasma concentrations: vitamin A [µmol/L] </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006751.pub5/references#CD006751-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006751.pub5/media/CDSR/CD006751/image_n/nCD006751-CMP-001.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006751-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006751.pub5/media/CDSR/CD006751/urn:x-wiley:14651858:media:CD006751:CD006751-CMP-001.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: β‐carotene supplementation versus placebo, Outcome 5: Plasma concentrations: β‐carotene [µmol/L]" data-id="CD006751-fig-0007" src="/cdsr/doi/10.1002/14651858.CD006751.pub5/media/CDSR/CD006751/image_n/nCD006751-CMP-001.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006751.pub5/media/CDSR/CD006751/image_t/tCD006751-CMP-001.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1: β‐carotene supplementation versus placebo, Outcome 5: Plasma concentrations: β‐carotene [µmol/L] </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006751.pub5/references#CD006751-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006751.pub5/media/CDSR/CD006751/image_n/nCD006751-CMP-001.05.svg" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD006751-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Summary of findings</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>β‐carotene supplementation</b> <b>compared to placebo in children and adults with CF</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population</b>: children and adults with CF </p> <p><b>Settings</b>: outpatient </p> <p><b>Intervention</b>: β‐carotene supplementation (month 1 to 3: high‐dose (1 mg/kg/day (max 50 mg/day); month 4 to 6: low‐dose (10 mg/day)) </p> <p><b>Comparison</b>: placebo </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign=""> <p><b>Relative effect</b> </p> <p><b>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>No of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Quality of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Assumed risk</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Corresponding risk</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Placebo</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>β‐carotene supplementation</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Vitamin A deficiency disorders</b> </p> <p>Follow‐up: NA</p> </td> <td align="" class="table-tint table-highlight" colspan="3" rowspan="1" valign="top"> <p>Outcome not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>We planned to assess visual impairment, any other ocular dysfunction and skin manifestations, but the included study did not report any of these. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Growth and nutritional status:</b> <br/><b>z‐score for height</b> </p> <p>Follow‐up: At 6 months (low‐dose)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean (SD) z score for height at 6 months was ‐0.81 (0.63) in the placebo group.</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean z score for height was 0.23 lower</p> <p>(0.89 lower to 0.43 higher) in the supplementation group.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>24</p> <p>(1 study)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/><b>Low<sup>1,2</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>We planned to assess weight (kg and z score), height (cm and z score) and BMI.</p> <p>No separate analysable weight data were reported, height was only reported as a z score and the authors stated no differences between groups for BMI. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mortality</b> </p> <p>Follow‐up: NA</p> </td> <td align="" class="table-tint table-highlight" colspan="3" rowspan="1" valign="top"> <p>Outcome not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Respiratory outcomes: FEV<sub>1</sub> (% predicted):</b> </p> <p>Follow‐up: At 3 months (high‐dose)</p> <p>Follow‐up: At 6 months (low‐dose)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>At 3 months mean (SD) FEV<sub>1</sub> (% predicted) was 82.2% (15.1) in the placebo group. </p> <p>At 6 months mean (SD) FEV<sub>1</sub> (% predicted) was 80.3% (19.1) in the placebo group. </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>At 3 months mean FEV<sub>1</sub> (% predicted) was 10.6% lower (31.1% lower to 9.9% higher) in the supplementation group. </p> <p>At 6 months mean FEV<sub>1</sub> (% predicted) was 10.3% lower (31.6% lower to 11.0% higher) in the supplementation group. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>24</p> <p>(1 study)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/><b>Low<sup>1,2</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Respiratory outcomes: Antibiotic days per patient in past 3 months</b> </p> <p>Follow‐up: At 3 months (high‐dose)</p> <p>Follow‐up: At 6 months (low‐dose)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>At 3 months the mean (SD) number of antibiotic days was 24.8 (19.1) days in the placebo group. </p> <p>At 6 months the mean (SD) number of antibiotic days was 18.5 (15.8) days in the placebo group. </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>At 3 months the mean number of antibiotic days was 15.0 days lower (27.6 lower to 2.4 lower) in the supplementation group. </p> <p>At 6 months the mean number of antibiotic days was 8.0 days lower (18.8 days lower to 2.8 days higher) in the supplementation group. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>24</p> <p>(1 study)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/><b>Low<sup>1,2</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse events</b> </p> <p>Follow‐up: At 6 months<br/>(low‐dose) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>No adverse events reported.</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>No adverse events reported.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>24<br/>(1 study) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/><b>Low</b><sup>1,3</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Authors only mentioned that no adverse events were observed, without specification.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> is the event rate in the control group across studies. The <b>corresponding risk</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CF</b> : cystic fibrosis; <b>CI</b> : confidence interval; <b>FEV<sub>1</sub> </b> : forced expiratory volume in 1 second; <b>NA</b> : Not applicable; <b>SD</b>: standard deviation. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/><b>High quality</b> : further research is very unlikely to change our confidence in the estimate of effect.<br/><b>Moderate quality</b> : further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/><b>Low quality</b> : further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/><b>Very low quality</b>: we are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p>1. Downgraded once due risk of bias: unclear information relating to methodology such method of generation of random sequence, allocation concealment and blinding. Also due to the lack of an adequate wash‐out period post high‐dose supplementation, results post low‐dose supplementation might not be fully representative, increasing the risk of bias due to study design. </p> <p>2. Downgraded once due to imprecision: The CI crosses no difference and due to the wide CI minor differences are not ruled out. </p> <p>3. Downgraded once as no data are provided, only narrative.</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Summary of findings</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006751.pub5/full#CD006751-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD006751-tbl-0002"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">β‐carotene supplementation versus placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.1 Growth and nutritional status: z score for height <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1.1 At 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.2 Respiratory outcomes: FEV<sub>1</sub> (% predicted) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2.1 At 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2.2 At 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.3 Respiratory outcomes: antibiotic days per patient in past 3 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3.1 At 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3.2 At 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.4 Plasma concentrations: vitamin A [µmol/L] <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4.1 At 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4.2 At 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.5 Plasma concentrations: β‐carotene [µmol/L] <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.5.1 At 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.5.2 At 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">β‐carotene supplementation versus placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006751.pub5/references#CD006751-tbl-0002">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD006751.pub5&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD006751-note-0010">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD006751-note-0009">فارسی</a> </li> <li class="section-language"> <a class="" href="ja#CD006751-note-0008">日本語</a> </li> <li class="section-language"> <a class="" href="ms#CD006751-note-0007">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="ru#CD006751-note-0006">Русский</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD006751-note-0004">简体中文</a> </li> <li class="section-language"> <a class="" href="zh_HANT#CD006751-note-0005">繁體中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734739000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734739000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773542000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773471000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006751\x2epub5\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006751\x2epub5\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006751\x2epub5\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD006751\x2epub5"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006751\x2epub5\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006751\x2epub5\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006751\x2epub5\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006751\x2epub5\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006751\x2epub5\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD006751\x2epub5"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006751\x2epub5\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006751\x2epub5\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006751\x2epub5\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD006751\x2epub5"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006751\x2epub5\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006751\x2epub5\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006751\x2epub5\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD006751\x2epub5"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=i9CklieH&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD006751.pub5&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD006751.pub5';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD006751.pub5/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD006751.pub5/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD006751.pub5%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740717048628"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD006751.pub5/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740717048631"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD006751.pub5/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918dae68ab46f3f1',t:'MTc0MDcxNzA0OC4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 